Jeffrey Martin, MD, MPH

Title(s)Professor, Epidemiology & Biostatistics
SchoolSchool of Medicine
Address550 16th. Street
San Francisco CA 94158
Phone415-514-8010
ORCID ORCID Icon0000-0002-9773-3256 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Johns Hopkins University, Baltimore, MarylandBA05/1983Biology
    University of Pennsylvania, Philadelphia, PennsylvaniaMD05/1988Medicine
    University of California, San FranciscoInternship06/1989Internal Medicine
    University of California, San FranciscoResidency 06/1991Internal Medicine
    University of California, San FranciscoChief Residency06/1992Internal Medicine
    University of California, BerkeleyMPH05/1993Public Health-Epidemiology
    University of California, San FranciscoFellowship06/1997Infectious Diseases & Epidemiology

    Collapse Overview 
    Collapse Overview
    Dr. Martin is Professor and Chief of the Division of Clinical Epidemiology and Health Services Research in the Department of Epidemiology and Biostatistics at the University of California, San Francisco (UCSF). His clinical training is in internal medicine and infectious diseases, and he has served as attending physician at the San Francisco General Hospital HIV/AIDS program clinic. He is formally trained in clinical and epidemiologic research methods at UC Berkeley, where he earned a master of public health degree with concentration in epidemiology. He is currently director of UCSF's Training in Clinical Research (TICR) program (https://ticr.ucsf.edu), in which he serves as director of the UCSF Advanced Training in Clinical Research (ATCR) certificate program and the UCSF Master's Degree Program in Clinical Research. He is also one of the main architects of (and lecturers for) the epidemiology and biostatistics curriculum for the UCSF School of Medicine.

    Dr. Martin's research methodology is best characterized as using the methods of epidemiology and biostatistics to derive biologic and clinical inferences. His substantive areas of interest are infectious diseases and cancer, with a special focus on HIV infection and its complications, notably Kaposi's sarcoma (KS), Kaposi's sarcoma–associated herpesvirus (KSHV) infection and cervical cancer. All of his work is collaborative and multidisciplinary; indeed, all of his projects are built specifically as robust platforms to support a variety of collaborative projects. Because of the compelling nature of the HIV epidemic in Africa, much of his work in the past several years has centered there.

    Dr. Martin's principal domestic research involves direction, along with Dr. Steven Deeks, of the NIH-sponsored Study of the Consequences of the Protease Inhibitor Era (SCOPE), a prospective cohort of HIV-infected adults. SCOPE was established to conduct translational research related to HIV, with the overarching objective to provide research access to a group of well-characterized, contemporary HIV-infected patients of diverse demographic and clinical status (https://cfar.ucsf.edu/cores/clinical-and-population-sciences). SCOPE, which contributes to the North American International Epidemiologic Databases to Evaluate AIDS (IeDEA) consortium, also serves as a fertile training ground, with many faculty members owning NIH K awards that depend on the cohort. Dr. Martin also directs the Specimen Core of the eight-site Center for AIDS Research Network of Integrated Clinical Systems (CNICS) Cohort (https://www.uab.edu/cnics). CNICS has documented the routine course of clinical care from over 35,000 HIV-infected adults and collected serial biological specimens from a large fraction. The Specimen Core supports projects which seek to discover causal or predictive determinants of various clinical phenotypes as well as to describe various human host or pathogen-related parameters in a large nationally representative in-care population.

    In international research, Dr. Martin leads several NIH-sponsored ongoing projects in Africa. The first, performed in collaboration with the East Africa IeDEA network and Infectious Diseases Institute (IDI) in Uganda, is one of the first uses of rapid case ascertainment to study cancer in Africa. Dr. Martin’s group is performing RCA to study various aspects of Kaposi’s sarcoma, including incidence, pathway to diagnosis, stage of disease at diagnosis, and survival. The second project, in collaboration with Cornell University and the IDI, is developing a nucleic acid amplification-based device for the point-of-care diagnosis of KS. The work is slated to have field sites in Uganda, Kenya, Rwanda, Tanzania, Botswana, and Malawi. A third project, performed in collaboration with Duke University and the IDI, is developing a public health approach to the prevention and early detection of cervical cancer. This approach features community-based self-administered HPV screening and mobile treatment provision. A fourth project is the Uganda AIDS Rural Treatment Outcomes (UARTO) cohort, which followed 744 HIV-infected adults who initiated antiretroviral therapy in Mbarara, Uganda. Patterned after the SCOPE cohort, UARTO features rigorous research-level questionnaires and biological specimen collection; the focus is translational research. Finally, in Liberia, Dr. Martin and Dr. Krysia Lindan lead an NIH Fogarty International Center-sponsored training program in clinical and epidemiologic research in which Liberian scholars receive formal didactic training at UCSF and then perform mentored research in their home country.
    Collapse In The News

    Collapse Research 
    Collapse Research Activities and Funding
    United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers
    NIH U54CA254571Jul 13, 2020 - Jun 30, 2025
    Role: Principal Investigator
    Training in Clinical and Epidemiological Research for Liberia (TRACER)
    NIH U2RTW011281Aug 10, 2019 - Apr 30, 2024
    Role: Principal Investigator
    Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect
    NIH UH3CA202723Aug 17, 2016 - Jul 31, 2022
    Role: Co-Principal Investigator
    Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect
    NIH UH2CA202723Aug 17, 2016 - Jul 31, 2018
    Role: Co-Principal Investigator
    Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer
    NIH U54CA190153Sep 17, 2014 - Aug 31, 2020
    Role: Principal Investigator
    Uganda-UCSF Research Training in HIV-Associated Malignancies
    NIH D43CA153717Sep 9, 2010 - Aug 31, 2015
    Role: Principal Investigator
    Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa
    NIH R01CA119903Sep 30, 2005 - Jul 31, 2012
    Role: Principal Investigator
    Center for AIDS Prevention Studies
    NIH P30MH062246Sep 24, 2001 - Aug 31, 2021
    Role: Co-Investigator
    UCSF-Gladstone Center for AIDS Research
    NIH P30AI027763Mar 1, 1997 - Aug 31, 2022
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Accumulation of HIV-1 Drug Resistance Mutations and Methamphetamine Use. Curr HIV Res. 2021 Jun 24. Truong HM, Fatch R, Deeks SG, Krone M, Martin JN, Hunt PW, Lum PJ. PMID: 34176462.
      View in: PubMed   Mentions:    Fields:    
    2. Treated HIV Infection and Progression of Carotid Atherosclerosis in Rural Uganda: A Prospective Observational Cohort Study. J Am Heart Assoc. 2021 Jun 15; 10(12):e019994. Siedner MJ, Bibangambah P, Kim JH, Lankowski A, Chang JL, Yang IT, Kwon DS, North CM, Triant VA, Longenecker C, Ghoshhajra B, Peck RN, Sentongo RN, Gilbert R, Kakuhikire B, Boum Y, Haberer JE, Martin JN, Tracy R, Hunt PW, Bangsberg DR, Tsai AC, Hemphill LC, Okello S. PMID: 34096320.
      View in: PubMed   Mentions:    Fields:    
    3. Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda. AIDS. 2021 06 01; 35(7):1083-1089. McCluskey SM, Kamelian K, Musinguzi N, Kigozi S, Boum Y, Bwana MB, Muzoora C, Brumme ZL, Carrington M, Carlson J, Foley B, Hunt PW, Martin JN, Bangsberg DR, Harrigan PR, Siedner MJ, Haberer JE, Lee GQ. PMID: 33635845.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus. J Infect Dis. 2021 May 20; 223(9):1621-1630. Schnittman SR, Deitchman AN, Beck-Engeser G, Ahn H, York VA, Hartig H, Hecht FM, Martin JN, Deeks SG, Aweeka FT, Hunt PW. PMID: 32915986.
      View in: PubMed   Mentions: 2     Fields:    
    5. Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection. Open Forum Infect Dis. 2021 Jun; 8(6):ofab245. Schnittman SR, Byakwaga H, Boum Y, Kabakyenga J, Matthews LT, Burdo TH, Huang Y, Tracy RP, Haberer JE, Kembabazi A, Kaida A, Moisi D, Lederman MM, Bangsberg DR, Martin JN, Hunt PW. PMID: 34159218.
      View in: PubMed   Mentions:
    6. Indoleamine 2,3 dioxygenase, age, and immune activation in people living with HIV. J Investig Med. 2021 Apr 19. Baer SL, Colombo RE, Johnson MH, Wakade S, Pacholczyk G, Newman-Whitlow C, Thompson SA, Saag MS, Martin JN, Floris-Moore M, Huang L, Mellor AL. PMID: 33875612.
      View in: PubMed   Mentions:    Fields:    
    7. Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19. medRxiv. 2021 Mar 12. Peluso MJ, Kelly JD, Lu S, Goldberg SA, Davidson MC, Mathur S, Durstenfeld MS, Spinelli MA, Hoh R, Tai V, Fehrman EA, Torres L, Hernandez Y, Williams MC, Arreguin MI, Bautista JA, Ngo LH, Deswal M, Munter SE, Martinez EO, Anglin KA, Romero MD, Tavs J, Rugart PR, Chen JY, Sans HM, Murray VW, Ellis PK, Donohue KC, Massachi JA, Weiss JO, Mehdi I, Pineda-Ramirez J, Tang AF, Wenger M, Assenzio M, Yuan Y, Krone M, Rutishauser RL, Rodriguez-Barraquer I, Greenhouse B, Sauceda JA, Gandhi M, Hsue PY, Henrich TJ, Deeks SG, Martin JN. PMID: 33758895.
      View in: PubMed   Mentions:
    8. Characterizing the COVID-19 illness experience to inform the study of post-acute sequalae and recovery: a qualitative study. medRxiv. 2021 Mar 12. Santiago-Rodriguez EI, Maiorana A, Peluso MJ, Hoh R, Tai V, Fehrman EA, Hernandez Y, Torres L, Spinelli MA, Gandhi M, Kelly JD, Martin JN, Henrich TJ, Deeks SG, Sauceda JA. PMID: 33758881.
      View in: PubMed   Mentions:
    9. SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay. medRxiv. 2021 Mar 05. Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, Vallari A, Rodgers MA, Prostko J, Hackett J, Trinh L, Wrin T, Petroplolous CJ, Chiu CY, Norris PJ, DiGermanio C, Stone M, Busch MP, Elledge SK, Zhou XX, Wells JA, Shu A, Kurtz TW, Pak JE, Wu W, Burbelo PD, Cohen JI, Rutishauser RL, Martin JN, Deeks SG, Henrich TJ, Rodriguez-Barraquer I, Greenhouse B. PMID: 33688675.
      View in: PubMed   Mentions:
    10. Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19. medRxiv. 2021 Mar 01. Peluso MJ, Deitchman AN, Torres L, Iyer NS, Nixon CC, Munter SE, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman E, Spinelli MA, Gandhi M, Trinh L, Wrin T, Petropoulos CJ, Aweeka FT, Rodriguez-Barraquer I, Kelly JD, Martin JN, Deeks SG, Greenhouse B, Rutishauser RL, Henrich TJ. PMID: 33688685.
      View in: PubMed   Mentions:
    11. Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations. Cells. 2021 02 13; 10(2). Sun B, Tang N, Peluso MJ, Iyer NS, Torres L, Donatelli JL, Munter SE, Nixon CC, Rutishauser RL, Rodriguez-Barraquer I, Greenhouse B, Kelly JD, Martin JN, Deeks SG, Henrich TJ, Pulliam L. PMID: 33668514.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    12. TCF-1 regulates HIV-specific CD8+ T cell expansion capacity. JCI Insight. 2021 02 08; 6(3). Rutishauser RL, Deguit CDT, Hiatt J, Blaeschke F, Roth TL, Wang L, Raymond KA, Starke CE, Mudd JC, Chen W, Smullin C, Matus-Nicodemos R, Hoh R, Krone M, Hecht FM, Pilcher CD, Martin JN, Koup RA, Douek DC, Brenchley JM, Sékaly RP, Pillai SK, Marson A, Deeks SG, McCune JM, Hunt PW. PMID: 33351785.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    13. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J Neurovirol. 2021 02; 27(1):191-195. Hellmuth J, Barnett TA, Asken BM, Kelly JD, Torres L, Stephens ML, Greenhouse B, Martin JN, Chow FC, Deeks SG, Greene M, Miller BL, Annan W, Henrich TJ, Peluso MJ. PMID: 33528824.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    14. Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART. PLoS Pathog. 2021 01; 17(1):e1009214. Bacchus-Souffan C, Fitch M, Symons J, Abdel-Mohsen M, Reeves DB, Hoh R, Stone M, Hiatt J, Kim P, Chopra A, Ahn H, York VA, Cameron DL, Hecht FM, Martin JN, Yukl SA, Mallal S, Cameron PU, Deeks SG, Schiffer JT, Lewin SR, Hellerstein MK, McCune JM, Hunt PW. PMID: 33465157.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    15. E Values and Incidence Density Sampling. Epidemiology. 2020 11; 31(6):e51-e52. VanderWeele TJ, Martin JN, Mathur MB. PMID: 32769478.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Association of Viral Persistence and Atherosclerosis in Adults With Treated HIV Infection. JAMA Netw Open. 2020 10 01; 3(10):e2018099. McLaughlin MM, Ma Y, Scherzer R, Rahalkar S, Martin JN, Mills C, Milush J, Deeks SG, Hsue PY. PMID: 33119103.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Super learner analysis of real-time electronically monitored adherence to antiretroviral therapy under constrained optimization and comparison to non-differentiated care approaches for persons living with HIV in rural Uganda. J Int AIDS Soc. 2020 03; 23(3):e25467. Benitez AE, Musinguzi N, Bangsberg DR, Bwana MB, Muzoora C, Hunt PW, Martin JN, Haberer JE, Petersen ML. PMID: 32202067.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    18. Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy. JCI Insight. 2020 02 27; 5(4). Peluso MJ, Bacchetti P, Ritter KD, Beg S, Lai J, Martin JN, Hunt PW, Henrich TJ, Siliciano JD, Siliciano RF, Laird GM, Deeks SG. PMID: 32045386.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    19. Antiretroviral Therapy Adherence Interruptions Are Associated With Systemic Inflammation Among Ugandans Who Achieved Viral Suppression. J Acquir Immune Defic Syndr. 2019 12 01; 82(4):386-391. Musinguzi N, Castillo-Mancilla J, Morrow M, Byakwaga H, Mawhinney S, Burdo TH, Boum Y, Muzoora C, Bwana BM, Siedner MJ, Martin JN, Hunt PW, Bangsberg DR, Haberer JE. PMID: 31658181.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. Some Aspects of CD8+ T-Cell Exhaustion Are Associated With Altered T-Cell Mitochondrial Features and ROS Content in HIV Infection. J Acquir Immune Defic Syndr. 2019 10 01; 82(2):211-219. Deguit CDT, Hough M, Hoh R, Krone M, Pilcher CD, Martin JN, Deeks SG, McCune JM, Hunt PW, Rutishauser RL. PMID: 31513075.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    21. High Incidence of Intended Partner Pregnancy Among Men Living With HIV in Rural Uganda: Implications for Safer Conception Services. . 2019 08 15; 81(5):497-507. Kaida A, Kabakyenga J, Bwana M, Bajunirwe F, Muyindike W, Bennett K, Kembabazi A, Haberer JE, Boum Y, Martin JN, Hunt PW, Bangsberg DR, Matthews LT. PMID: 30973545.
      View in: PubMed   Mentions:
    22. Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral Therapy. . 2019 01 01; 80(1):89-93. Carrico AW, Hunt PW, Neilands TB, Dilworth SE, Martin JN, Deeks SG, Riley ED. PMID: 30272634.
      View in: PubMed   Mentions:
    23. Contraceptive use following unintended pregnancy among Ugandan women living with HIV. PLoS One. 2018; 13(10):e0206325. Jarolimova J, Kabakyenga J, Bennett K, Muyindike W, Kembabazi A, Martin JN, Hunt PW, Boum Y, Haberer JE, Bangsberg DR, Kaida A, Matthews LT. PMID: 30359430.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. HLA-C downregulation by HIV-1 adapts to host HLA genotype. PLoS Pathog. 2018 09; 14(9):e1007257. Bachtel ND, Umviligihozo G, Pickering S, Mota TM, Liang H, Del Prete GQ, Chatterjee P, Lee GQ, Thomas R, Brockman MA, Neil S, Carrington M, Bwana B, Bangsberg DR, Martin JN, Kallas EG, Donini CS, Cerqueira NB, O'Doherty UT, Hahn BH, Jones RB, Brumme ZL, Nixon DF, Apps R. PMID: 30180214.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    25. Prevalence and correlates of physical and sexual intimate partner violence among women living with HIV in Uganda. PLoS One. 2018; 13(8):e0202992. Young CR, Kaida A, Kabakyenga J, Muyindike W, Musinguzi N, Martin JN, Hunt PW, Bangsberg DR, Haberer JE, Matthews LT. PMID: 30148854.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    26. Distribution and Performance of Cardiovascular Risk Scores in a Mixed Population of HIV-Infected and Community-Based HIV-Uninfected Individuals in Uganda. . 2018 08 01; 78(4):458-464. Muiru AN, Bibangambah P, Hemphill L, Sentongo R, Kim JH, Triant VA, Bangsberg DR, Tsai AC, Martin JN, Haberer JE, Boum Y, Plutzky J, Hunt PW, Okello S, Siedner MJ. PMID: 29652762.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    27. Mast Cell Activation and KSHV Infection in Kaposi Sarcoma. Clin Cancer Res. 2018 10 15; 24(20):5085-5097. Ayers LW, Barbachano-Guerrero A, McAllister SC, Ritchie JA, Asiago-Reddy E, Bartlett LC, Cesarman E, Wang D, Rochford R, Martin JN, King CA. PMID: 30084838.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    28. As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis. 2018 07 02; 67(2):251-260. Hosseinipour MC, Kang M, Krown SE, Bukuru A, Umbleja T, Martin JN, Orem J, Godfrey C, Hoagland B, Mwelase N, Langat D, Nyirenda M, MacRae J, Borok M, Samaneka W, Moses A, Mngqbisa R, Busakhala N, Martínez-Maza O, Ambinder R, Dittmer DP, Nokta M, Campbell TB, A5264/AMC-067 REACT-KS Team . PMID: 29365083.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    29. Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005-2013. AIDS Patient Care STDS. 2018 07; 32(7):257-264. McCluskey SM, Lee GQ, Kamelian K, Kembabazi A, Musinguzi N, Bwana MB, Muzoora C, Haberer JE, Hunt PW, Martin JN, Boum Y, Bangsberg DR, Harrigan PR, Siedner MJ. PMID: 29985647.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    30. Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda: A Prospective Cohort Study. Ann Intern Med. 2018 08 07; 169(3):146-155. Chang JL, Tsai AC, Musinguzi N, Haberer JE, Boum Y, Muzoora C, Bwana M, Martin JN, Hunt PW, Bangsberg DR, Siedner MJ. PMID: 29946683.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    31. Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression. . 2018 04 15; 77(5):507-513. Castillo-Mancilla JR, Morrow M, Boum Y, Byakwaga H, Haberer JE, Martin JN, Bangsberg D, Mawhinney S, Musinguzi N, Huang Y, Tracy RP, Burdo TH, Williams K, Muzzora C, Hunt PW, Siedner MJ. PMID: 29346185.
      View in: PubMed   Mentions:
    32. Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States. Clin Infect Dis. 2018 04 03; 66(8):1230-1238. Wong C, Gange SJ, Moore RD, Justice AC, Buchacz K, Abraham AG, Rebeiro PF, Koethe JR, Martin JN, Horberg MA, Boyd CM, Kitahata MM, Crane HM, Gebo KA, Gill MJ, Silverberg MJ, Palella FJ, Patel P, Samji H, Thorne J, Rabkin CS, Mayor A, Althoff KN, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) . PMID: 29149237.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    33. Viral protein Nef is detected in plasma of half of HIV-infected adults with undetectable plasma HIV RNA. PLoS One. 2018; 13(1):e0191613. Ferdin J, Goricar K, Dolžan V, Plemenitaš A, Martin JN, Peterlin BM, Deeks SG, Lenassi M. PMID: 29364927.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    34. Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells. Science. 2018 01 05; 359(6371):86-90. Ramsuran V, Naranbhai V, Horowitz A, Qi Y, Martin MP, Yuki Y, Gao X, Walker-Sperling V, Del Prete GQ, Schneider DK, Lifson JD, Fellay J, Deeks SG, Martin JN, Goedert JJ, Wolinsky SM, Michael NL, Kirk GD, Buchbinder S, Haas D, Ndung'u T, Goulder P, Parham P, Walker BD, Carlson JM, Carrington M. PMID: 29302013.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    35. Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms. . 2017 12 15; 76(5):547-555. Grebe E, Welte A, Hall J, Keating SM, Facente SN, Marson K, Martin JN, Little SJ, Price MA, Kallas EG, Busch MP, Pilcher CD, Murphy G. PMID: 28914669.
      View in: PubMed   Mentions:
    36. Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals. J Virol. 2018 01 01; 92(1). Mwimanzi F, Toyoda M, Mahiti M, Mann JK, Martin JN, Bangsberg D, Brockman MA, Goulder P, Kirchhoff F, Brumme ZL, Ndung'u T, Ueno T. PMID: 29046444.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    37. Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection. J Virol. 2017 12 01; 91(23). Teigler JE, Zelinskyy G, Eller MA, Bolton DL, Marovich M, Gordon AD, Alrubayyi A, Alter G, Robb ML, Martin JN, Deeks SG, Michael NL, Dittmer U, Streeck H. PMID: 28904197.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    38. Prevalence and clinical impacts of HIV-1 intersubtype recombinants in Uganda revealed by near-full-genome population and deep sequencing approaches. AIDS. 2017 11 13; 31(17):2345-2354. Lee GQ, Bangsberg DR, Mo T, Lachowski C, Brumme CJ, Zhang W, Lima VD, Boum Y, Mwebesa BB, Muzoora C, Andia I, Mbalibulha Y, Kembabazi A, Carroll R, Siedner MJ, Haberer JE, Mocello AR, Kigozi SH, Hunt PW, Martin JN, Harrigan PR. PMID: 28832407.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    39. Association of HIV-1 Gag-Specific IgG Antibodies With Natural Control of HIV-1 Infection in Individuals Not Carrying HLA-B*57: 01 Is Only Observed in Viremic Controllers. . 2017 11 01; 76(3):e90-e92. Tjiam MC, Morshidi MA, Sariputra L, Martin JN, Deeks SG, Tan DBA, Lee S, Fernandez S, French MA. PMID: 28604502.
      View in: PubMed   Mentions:
    40. Brief Report: Should Abacavir Be a First-Line Alternative for Adults With HIV in Sub-Saharan Africa? . 2017 10 01; 76(2):188-192. Lee GQ, McCluskey S, Boum Y, Hunt PW, Martin JN, Bangsberg DR, Gao X, Harrigan PR, Haberer JE, Siedner MJ. PMID: 28639996.
      View in: PubMed   Mentions:
    41. Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure. . 2017 10 01; 76(2):183-187. McCluskey SM, Boum Y, Musinguzi N, Haberer JE, Martin JN, Hunt PW, Marconi VC, Bangsberg DR, Siedner MJ. PMID: 28628529.
      View in: PubMed   Mentions:
    42. Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection. AIDS. 2017 09 10; 31(14):1935-1943. Gatanaga H, Brumme ZL, Adland E, Reyes-Terán G, Avila-Rios S, Mejía-Villatoro CR, Hayashida T, Chikata T, Van Tran G, Van Nguyen K, Meza RI, Palou EY, Valenzuela-Ponce H, Pascale JM, Porras-Cortés G, Manzanero M, Lee GQ, Martin JN, Carrington MN, John M, Mallal S, Poon AFY, Goulder P, Takiguchi M, Oka S, International HIV Adaptation Collaborative . PMID: 28650381.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    43. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers. Retrovirology. 2017 Aug 22; 14(1):41. de Mulder M, SenGupta D, Deeks SG, Martin JN, Pilcher CD, Hecht FM, Sacha JB, Nixon DF, Michaud HA. PMID: 28830571.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    44. Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population. J Acquir Immune Defic Syndr. 2017 08 15; 75(5):568-576. Drozd DR, Kitahata MM, Althoff KN, Zhang J, Gange SJ, Napravnik S, Burkholder GA, Mathews WC, Silverberg MJ, Sterling TR, Heckbert SR, Budoff MJ, Van Rompaey S, Delaney JAC, Wong C, Tong W, Palella FJ, Elion RA, Martin JN, Brooks JT, Jacobson LP, Eron JJ, Justice AC, Freiberg MS, Klein DB, Post WS, Saag MS, Moore RD, Crane HM. PMID: 28520615.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    45. Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression. J Virol. 2017 07 01; 91(13). Kiguoya MW, Mann JK, Chopera D, Gounder K, Lee GQ, Hunt PW, Martin JN, Ball TB, Kimani J, Brumme ZL, Brockman MA, Ndung'u T. PMID: 28424286.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    46. Duration of Viral Suppression and Risk of Rebound Viremia with First-Line Antiretroviral Therapy in Rural Uganda. AIDS Behav. 2017 Jun; 21(6):1735-1740. Musinguzi N, Mocello RA, Boum Y, Hunt PW, Martin JN, Haberer JE, Bangsberg DR, Siedner MJ. PMID: 27256394.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    47. Cooking fuel and respiratory symptoms among people living with HIV in rural Uganda. ERJ Open Res. 2017 Apr; 3(2). North CM, Valeri L, Hunt PW, Mocello AR, Martin JN, Boum Y, Haberer JE, Bangsberg DR, Christiani DC, Siedner MJ. PMID: 28534032.
      View in: PubMed   Mentions:
    48. Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy. J Infect Dis. 2017 04 15; 215(8):1270-1274. Lee S, Byakwaga H, Boum Y, Burdo TH, Williams KC, Lederman MM, Huang Y, Tracy RP, Cao H, Haberer JE, Kembabazi A, Bangsberg DR, Martin JN, Hunt PW. PMID: 28329310.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    49. Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression. J Virol. 2017 03 15; 91(6). Jacobs ES, Keating SM, Abdel-Mohsen M, Gibb SL, Heitman JW, Inglis HC, Martin JN, Zhang J, Kaidarova Z, Deng X, Wu S, Anastos K, Crystal H, Villacres MC, Young M, Greenblatt RM, Landay AL, Gange SJ, Deeks SG, Golub ET, Pillai SK, Norris PJ. PMID: 28053103.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    50. Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoring. AIDS. 2017 01 02; 31(1):169-171. Haberer JE, Musinguzi N, Tsai AC, Boum Y, Bwana BM, Muzoora C, Hunt PW, Martin JN, Bangsberg DR. PMID: 27835622.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    51. Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population Incidence. . 2016 Dec 15; 73(5):581-588. Keating SM, Kassanjee R, Lebedeva M, Facente SN, MacArthur JC, Grebe E, Murphy G, Welte A, Martin JN, Little S, Price MA, Kallas EG, Busch MP, Pilcher CD. PMID: 27509247.
      View in: PubMed   Mentions:
    52. D-Dimer Levels and Traditional Risk Factors Are Associated With Incident Hypertension Among HIV-Infected Individuals Initiating Antiretroviral Therapy in Uganda. . 2016 Dec 01; 73(4):396-402. Okello S, Asiimwe SB, Kanyesigye M, Muyindike WR, Boum Y, Mwebesa BB, Haberer JE, Huang Y, Williams K, Burdo TH, Tracy RP, Bangsberg DR, Mocello AR, Martin JN, Hunt PW, Siedner MJ. PMID: 27171743.
      View in: PubMed   Mentions:
    53. Viral load criteria and threshold optimization to improve HIV incidence assay characteristics. AIDS. 2016 09 24; 30(15):2361-71. Kassanjee R, Pilcher CD, Busch MP, Murphy G, Facente SN, Keating SM, Mckinney E, Marson K, Price MA, Martin JN, Little SJ, Hecht FM, Kallas EG, Welte A, Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) . PMID: 27454561.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    54. Trends in one-year cumulative incidence of death between 2005 and 2013 among patients initiating antiretroviral therapy in Uganda. Int J STD AIDS. 2017 07; 28(8):800-807. Bebell LM, Siedner MJ, Musinguzi N, Boum Y, Bwana BM, Muyindike W, Hunt PW, Martin JN, Bangsberg DR. PMID: 27651351.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    55. Ideal Cardiovascular Health and Carotid Atherosclerosis in a Mixed Cohort of HIV-Infected and Uninfected Ugandans. AIDS Res Hum Retroviruses. 2017 01; 33(1):49-56. Feinstein MJ, Kim JH, Bibangambah P, Sentongo R, Martin JN, Tsai AC, Bangsberg DR, Hemphill L, Triant VA, Boum Y, Hunt PW, Okello S, Siedner MJ. PMID: 27476547.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    56. Relationship Power and Sexual Violence Among HIV-Positive Women in Rural Uganda. AIDS Behav. 2016 09; 20(9):2045-53. Conroy AA, Tsai AC, Clark GM, Boum Y, Hatcher AM, Kawuma A, Hunt PW, Martin JN, Bangsberg DR, Weiser SD. PMID: 27052844.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    57. Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans. AIDS. 2016 07 17; 30(11):1807-15. Lee SA, Mefford JA, Huang Y, Witte JS, Martin JN, Haas DW, Mclaren PJ, Mushiroda T, Kubo M, Byakwaga H, Hunt PW, Kroetz DL. PMID: 27088321.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    58. Non-R5-tropic HIV-1 in subtype A1 and D infections were associated with lower pretherapy CD4+ cell count but not with PI/(N)NRTI therapy outcomes in Mbarara, Uganda. AIDS. 2016 07 17; 30(11):1781-8. Lee GQ, Lachowski C, Cai E, Lima VD, Boum Y, Muzoora C, Mocello AR, Hunt PW, Martin JN, Bangsberg DR, Harrigan PR. PMID: 27124899.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    59. Association between Guillain-Barré syndrome and Zika virus infection. Lancet. 2016 Jun 25; 387(10038):2599. Avelino-Silva VI, Martin JN. PMID: 27353814.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    60. Immunologic profiles distinguish aviremic HIV-infected adults. AIDS. 2016 06 19; 30(10):1553-62. Ramirez CM, Sinclair E, Epling L, Lee SA, Jain V, Hsue PY, Hatano H, Conn D, Hecht FM, Martin JN, McCune JM, Deeks SG, Hunt PW. PMID: 26854811.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    61. Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. J Infect Dis. 2016 09 15; 214(6):862-72. Buchacz K, Lau B, Jing Y, Bosch R, Abraham AG, Gill MJ, Silverberg MJ, Goedert JJ, Sterling TR, Althoff KN, Martin JN, Burkholder G, Gandhi N, Samji H, Patel P, Rachlis A, Thorne JE, Napravnik S, Henry K, Mayor A, Gebo K, Gange SJ, Moore RD, Brooks JT, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA . PMID: 27559122.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    62. HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods. . 2016 Apr 01; 71(4):399-406. Matthews LT, Ribaudo HB, Kaida A, Bennett K, Musinguzi N, Siedner MJ, Kabakyenga J, Hunt PW, Martin JN, Boum Y, Haberer JE, Bangsberg DR. PMID: 26495883.
      View in: PubMed   Mentions:
    63. Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome. . 2016 Mar 09; 19(3):311-22. Monaco CL, Gootenberg DB, Zhao G, Handley SA, Ghebremichael MS, Lim ES, Lankowski A, Baldridge MT, Wilen CB, Flagg M, Norman JM, Keller BC, Luévano JM, Wang D, Boum Y, Martin JN, Hunt PW, Bangsberg DR, Siedner MJ, Kwon DS, Virgin HW. PMID: 26962942.
      View in: PubMed   Mentions:
    64. HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda. AIDS. 2016 Feb 20; 30(4):667-70. Siedner MJ, Kim JH, Nakku RS, Hemphill L, Triant VA, Haberer JE, Martin JN, Boum Y, Kwon DS, Tsai AC, Hunt PW, Okello S, Bangsberg DR. PMID: 26636926.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    65. Endothelin-1 Predicts Hemodynamically Assessed Pulmonary Arterial Hypertension in HIV Infection. PLoS One. 2016; 11(1):e0146355. Parikh RV, Ma Y, Scherzer R, Heringer AS, Macgregor JS, Martin JN, Deeks SG, Ganz P, Hsue PY. PMID: 26752193.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    66. Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda. . 2015 Dec 01; 70(4):386-92. Haberer JE, Musinguzi N, Boum Y, Siedner MJ, Mocello AR, Hunt PW, Martin JN, Bangsberg DR. PMID: 26110445.
      View in: PubMed   Mentions:
    67. The Kynurenine Pathway of Tryptophan Catabolism and AIDS-Associated Kaposi Sarcoma in Africa. . 2015 Nov 01; 70(3):296-303. Byakwaga H, Hunt PW, Laker-Oketta M, Glidden DV, Huang Y, Bwana BM, Mocello AR, Bennett J, Walusansa V, Dollard SC, Bangsberg DR, Mbidde EK, Martin JN. PMID: 26181812.
      View in: PubMed   Mentions:
    68. Implementation of electronic medical records requires more than new software: Lessons on integrating and managing health technologies from Mbarara, Uganda. Healthc (Amst). 2015 Dec; 3(4):264-9. Madore A, Rosenberg J, Muyindike WR, Bangsberg DR, Bwana MB, Martin JN, Kanyesigye M, Weintraub R. PMID: 26699355.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    69. Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy. J Infect Dis. 2016 Feb 01; 213(3):370-8. Siedner MJ, Kim JH, Nakku RS, Bibangambah P, Hemphill L, Triant VA, Haberer JE, Martin JN, Mocello AR, Boum Y, Kwon DS, Tracy RP, Burdo T, Huang Y, Cao H, Okello S, Bangsberg DR, Hunt PW. PMID: 26347573.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    70. Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor. Proc Natl Acad Sci U S A. 2015 Aug 25; 112(34):E4762-71. Gornalusse GG, Mummidi S, Gaitan AA, Jimenez F, Ramsuran V, Picton A, Rogers K, Manoharan MS, Avadhanam N, Murthy KK, Martinez H, Molano Murillo A, Chykarenko ZA, Hutt R, Daskalakis D, Shostakovich-Koretskaya L, Abdool Karim S, Martin JN, Deeks SG, Hecht F, Sinclair E, Clark RA, Okulicz J, Valentine FT, Martinson N, Tiemessen CT, Ndung'u T, Hunt PW, He W, Ahuja SK. PMID: 26307764.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    71. Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals. JACC Heart Fail. 2015 Aug; 3(8):591-9. Secemsky EA, Scherzer R, Nitta E, Wu AH, Lange DC, Deeks SG, Martin JN, Snider J, Ganz P, Hsue PY. PMID: 26164679.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    72. Mitral Annular and Coronary Artery Calcification Are Associated with Mortality in HIV-Infected Individuals. PLoS One. 2015; 10(7):e0130592. Lange DC, Glidden D, Secemsky EA, Ordovas K, Deeks SG, Martin JN, Bolger AF, Hsue PY. PMID: 26132465.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    73. Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 ?32. AIDS. 2015 May 15; 29(8):867-76. Henrich TJ, Hanhauser E, Hu Z, Stellbrink HJ, Noah C, Martin JN, Deeks SG, Kuritzkes DR, Pereyra F. PMID: 25730507.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    74. The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda. Contraception. 2015 Aug; 92(2):152-9. Nieves CI, Kaida A, Seage GR, Kabakyenga J, Muyindike W, Boum Y, Mocello AR, Martin JN, Hunt PW, Haberer JE, Bangsberg DR, Matthews LT. PMID: 25983013.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    75. Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification. J Immunol. 2015 Jun 01; 194(11):5320-8. Tjiam MC, Taylor JP, Morshidi MA, Sariputra L, Burrows S, Martin JN, Deeks SG, Tan DB, Lee S, Fernandez S, French MA. PMID: 25911748.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    76. Implementation and operational research: evaluating outcomes of patients lost to follow-up in a large comprehensive care treatment program in western Kenya. . 2015 Apr 01; 68(4):e46-55. Rachlis B, Ochieng D, Geng E, Rotich E, Ochieng V, Maritim B, Ndege S, Naanyu V, Martin JN, Keter A, Ayuo P, Diero L, Nyambura M, Braitstein P. PMID: 25692336.
      View in: PubMed   Mentions:
    77. Dynamic Visual Display of Treatment Response in HIV-Infected Adults. Clin Infect Dis. 2015 Jul 01; 61(1):e1-4. Edwards JK, Cole SR, Martin JN, Moore R, Mathews WC, Kitahata M, Eron JJ, Saag M, Mugavero MJ, CNICS Investigators . PMID: 25838289.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    78. Ten-year Survival by Race/Ethnicity and Sex Among Treated, HIV-infected Adults in the United States. Clin Infect Dis. 2015 Jun 01; 60(11):1700-7. Lesko CR, Cole SR, Miller WC, Westreich D, Eron JJ, Adimora AA, Moore RD, Mathews WC, Martin JN, Drozd DR, Kitahata MM, Edwards JK, Mugavero MJ. PMID: 25767258.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    79. CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa. Int J Epidemiol. 2015 Feb; 44(1):251-63. Geng EH, Neilands TB, Thièbaut R, Bwana MB, Nash D, Moore RD, Wood R, Zannou DM, Althoff KN, Lim PL, Nachega JB, Easterbrook PJ, Kambugu A, Little F, Nakigozi G, Nakanjako D, Kiggundu V, Ki Li PC, Bangsberg DR, Fox MP, Prozesky H, Hunt PW, Davies MA, Reynolds SJ, Egger M, Yiannoutsos CT, Vittinghoff EV, Deeks SG, Martin JN. PMID: 25859596.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    80. Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort study. Lancet HIV. 2015 03; 2(3):e107-16. Geng EH, Odeny TA, Lyamuya RE, Nakiwogga-Muwanga A, Diero L, Bwana M, Muyindike W, Braitstein P, Somi GR, Kambugu A, Bukusi EA, Wenger M, Wools-Kaloustian KK, Glidden DV, Yiannoutsos CT, Martin JN. PMID: 26424542.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    81. Prospective Study of the Mental Health Consequences of Sexual Violence Among Women Living With HIV in Rural Uganda. J Interpers Violence. 2016 May; 31(8):1531-53. Tsai AC, Wolfe WR, Kumbakumba E, Kawuma A, Hunt PW, Martin JN, Bangsberg DR, Weiser SD. PMID: 25586914.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    82. Persistent HIV-related stigma in rural Uganda during a period of increasing HIV incidence despite treatment expansion. AIDS. 2015 Jan 02; 29(1):83-90. Chan BT, Weiser SD, Boum Y, Siedner MJ, Mocello AR, Haberer JE, Hunt PW, Martin JN, Mayer KH, Bangsberg DR, Tsai AC. PMID: 25268886.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    83. Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS. 2015 Jan 02; 29(1):43-51. Somsouk M, Estes JD, Deleage C, Dunham RM, Albright R, Inadomi JM, Martin JN, Deeks SG, McCune JM, Hunt PW. PMID: 25387317.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    84. Declining prevalence of probable depression among patients presenting for antiretroviral therapy in rural Uganda: the role of early treatment initiation. AIDS Behav. 2015 Jan; 19(1):19-26. Chan BT, Weiser SD, Boum Y, Haberer JE, Kembabazi A, Hunt PW, Martin JN, Mocello AR, Bangsberg DR, Tsai AC. PMID: 24788780.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    85. The factor structure and presentation of depression among HIV-positive adults in Uganda. AIDS Behav. 2015 Jan; 19(1):27-33. Psaros C, Haberer JE, Boum Y, Tsai AC, Martin JN, Hunt PW, Bangsberg DR, Safren SA. PMID: 24854877.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    86. The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD4+ T cell recovery: a randomized crossover trial. PLoS One. 2014; 9(12):e116306. Somsouk M, Dunham RM, Cohen M, Albright R, Abdel-Mohsen M, Liegler T, Lifson J, Piatak M, Gorelick R, Huang Y, Wu Y, Hsue PY, Martin JN, Deeks SG, McCune JM, Hunt PW. PMID: 25545673.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    87. Comparison of self-reported alcohol consumption to phosphatidylethanol measurement among HIV-infected patients initiating antiretroviral treatment in southwestern Uganda. PLoS One. 2014; 9(12):e113152. Bajunirwe F, Haberer JE, Boum Y, Hunt P, Mocello R, Martin JN, Bangsberg DR, Hahn JA. PMID: 25436894.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    88. Depression during pregnancy and the postpartum among HIV-infected women on antiretroviral therapy in Uganda. . 2014 Dec 01; 67 Suppl 4:S179-87. Kaida A, Matthews LT, Ashaba S, Tsai AC, Kanters S, Robak M, Psaros C, Kabakyenga J, Boum Y, Haberer JE, Martin JN, Hunt PW, Bangsberg DR. PMID: 25436816.
      View in: PubMed   Mentions:
    89. Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS. 2014 Oct 23; 28(16):2439-49. Kassanjee R, Pilcher CD, Keating SM, Facente SN, McKinney E, Price MA, Martin JN, Little S, Hecht FM, Kallas EG, Welte A, Busch MP, Murphy G, Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) . PMID: 25144218.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    90. Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa. AIDS. 2014 Sep 10; 28(14):2097-107. Petersen ML, Tran L, Geng EH, Reynolds SJ, Kambugu A, Wood R, Bangsberg DR, Yiannoutsos CT, Deeks SG, Martin JN. PMID: 24977440.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    91. Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals. PLoS Pathog. 2014 Aug; 10(8):e1004345. Klatt NR, Bosinger SE, Peck M, Richert-Spuhler LE, Heigele A, Gile JP, Patel N, Taaffe J, Julg B, Camerini D, Torti C, Martin JN, Deeks SG, Sinclair E, Hecht FM, Lederman MM, Paiardini M, Kirchhoff F, Brenchley JM, Hunt PW, Silvestri G. PMID: 25167059.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    92. Empiric deworming and CD4 count recovery in HIV-infected Ugandans initiating antiretroviral therapy. PLoS Negl Trop Dis. 2014 Aug; 8(8):e3036. Lankowski AJ, Tsai AC, Kanyesigye M, Bwana M, Haberer JE, Wenger M, Martin JN, Bangsberg DR, Hunt PW, Siedner MJ. PMID: 25101890.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    93. Levels of circulating myeloid subpopulations and of heme oxygenase-1 do not predict CD4(+) T cell recovery after the initiation of antiretroviral therapy for HIV disease. AIDS Res Ther. 2014; 11:27. Seu L, Ortiz GM, Burt TD, Deeks SG, Martin JN, McCune JM. PMID: 25180041.
      View in: PubMed   Mentions: 2     Fields:    
    94. The dynamic relationship between social support and HIV-related stigma in rural Uganda. Ann Behav Med. 2014 Aug; 48(1):26-37. Takada S, Weiser SD, Kumbakumba E, Muzoora C, Martin JN, Hunt PW, Haberer JE, Kawuma A, Bangsberg DR, Tsai AC. PMID: 24500077.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    95. Programmed death-1 expression on CD4? and CD8? T cells in treated and untreated HIV disease. AIDS. 2014 Jul 31; 28(12):1749-58. Cockerham LR, Jain V, Sinclair E, Glidden DV, Hartogenesis W, Hatano H, Hunt PW, Martin JN, Pilcher CD, Sekaly R, McCune JM, Hecht FM, Deeks SG. PMID: 24871455.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    96. Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda. AIDS Res Hum Retroviruses. 2014 Sep; 30(9):896-906. Lee GQ, Bangsberg DR, Muzoora C, Boum Y, Oyugi JH, Emenyonu N, Bennett J, Hunt PW, Knapp D, Brumme CJ, Harrigan PR, Martin JN. PMID: 24960249.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    97. Cutting edge: An antibody recognizing ancestral endogenous virus glycoproteins mediates antibody-dependent cellular cytotoxicity on HIV-1-infected cells. J Immunol. 2014 Aug 15; 193(4):1544-8. Michaud HA, SenGupta D, de Mulder M, Deeks SG, Martin JN, Kobie JJ, Sacha JB, Nixon DF. PMID: 25024383.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    98. Tobacco use among adults initiating treatment for HIV infection in rural Uganda. AIDS Behav. 2014 Jul; 18(7):1381-9. Kruse GR, Bangsberg DR, Hahn JA, Haberer JE, Hunt PW, Muzoora C, Bennett JP, Martin JN, Rigotti NA. PMID: 24638166.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    99. Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapy. Am J Epidemiol. 2015 Feb 15; 181(4):238-45. Cole SR, Lau B, Eron JJ, Brookhart MA, Kitahata MM, Martin JN, Mathews WC, Mugavero MJ, CNICS Research Network . PMID: 24966220.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    100. Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers. AIDS Res Hum Retroviruses. 2014 Jul; 30(7):654-64. Tandon R, Chew GM, Byron MM, Borrow P, Niki T, Hirashima M, Barbour JD, Norris PJ, Lanteri MC, Martin JN, Deeks SG, Ndhlovu LC. PMID: 24786365.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    101. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog. 2014 May; 10(5):e1004078. Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, Ferre AL, Hayes TL, Somsouk M, Hsue PY, Van Natta ML, Meinert CL, Lederman MM, Hatano H, Jain V, Huang Y, Hecht FM, Martin JN, McCune JM, Moreno S, Deeks SG. PMID: 24831517.
      View in: PubMed   Mentions: 192     Fields:    Translation:HumansCells
    102. A closer look at hepatitis C clearance in HIV controllers: a response. AIDS. 2014 May 15; 28(8):1241-2. Asher AK, Santos GM, Evans J, Dokubo EK, Lee TH, Martin JN, Deeks SG, Tobler LH, Busch M, Hunt PW, Page K. PMID: 25028914.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    103. CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda. AIDS. 2014 May 15; 28(8):1221-6. Venkataramani AS, Thirumurthy H, Haberer JE, Ii YB, Siedner MJ, Kembabazi A, Hunt PW, Martin JN, Bangsberg DR, Tsai AC. PMID: 24406678.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    104. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J Infect Dis. 2014 Oct 15; 210(8):1228-38. Hunt PW, Sinclair E, Rodriguez B, Shive C, Clagett B, Funderburg N, Robinson J, Huang Y, Epling L, Martin JN, Deeks SG, Meinert CL, Van Natta ML, Jabs DA, Lederman MM. PMID: 24755434.
      View in: PubMed   Mentions: 203     Fields:    Translation:HumansCells
    105. Point-of-care C-reactive protein testing to facilitate implementation of isoniazid preventive therapy for people living with HIV. . 2014 Apr 15; 65(5):551-6. Yoon C, Davis JL, Huang L, Muzoora C, Byakwaga H, Scibetta C, Bangsberg DR, Nahid P, Semitala FC, Hunt PW, Martin JN, Cattamanchi A. PMID: 24346636.
      View in: PubMed   Mentions:
    106. Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection. J Infect Dis. 2014 Aug 01; 210(3):374-82. Lee SA, Sinclair E, Jain V, Huang Y, Epling L, Van Natta M, Meinert CL, Martin JN, McCune JM, Deeks SG, Lederman MM, Hecht FM, Hunt PW. PMID: 24585893.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    107. The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy. J Infect Dis. 2014 Aug 01; 210(3):383-91. Byakwaga H, Boum Y, Huang Y, Muzoora C, Kembabazi A, Weiser SD, Bennett J, Cao H, Haberer JE, Deeks SG, Bangsberg DR, McCune JM, Martin JN, Hunt PW. PMID: 24585899.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    108. Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging. PLoS One. 2014; 9(2):e89444. Lee SA, Sinclair E, Hatano H, Hsue PY, Epling L, Hecht FM, Bangsberg DR, Martin JN, McCune JM, Deeks SG, Hunt PW. PMID: 24586783.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    109. Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection. AIDS. 2014 Feb 20; 28(4):511-9. Parikh RV, Scherzer R, Nitta EM, Leone A, Hur S, Mistry V, Macgregor JS, Martin JN, Deeks SG, Ganz P, Hsue PY. PMID: 24469026.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    110. Discordance between peripheral and colonic markers of inflammation during suppressive ART. . 2014 Feb 01; 65(2):133-41. Dunham RM, Vujkovic-Cvijin I, Yukl SA, Broadhurst MJ, Loke P, Albright RG, Wong JK, Lederman MM, Somsouk M, Hunt PW, Martin JN, Deeks SG, McCune JM. PMID: 24121758.
      View in: PubMed   Mentions:
    111. Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection. Retrovirology. 2014 Jan 28; 11:10. Michaud HA, de Mulder M, SenGupta D, Deeks SG, Martin JN, Pilcher CD, Hecht FM, Sacha JB, Nixon DF. PMID: 24472118.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    112. Composition and function of T cell subpopulations are slow to change despite effective antiretroviral treatment of HIV disease. PLoS One. 2014; 9(1):e85613. Emu B, Moretto WJ, Hoh R, Krone M, Martin JN, Nixon DF, Deeks SG, McCune JM. PMID: 24465619.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    113. Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda. AIDS. 2014 Jan 14; 28(2):267-71. Siedner MJ, Musinguzi N, Tsai AC, Muzoora C, Kembabazi A, Weiser SD, Bennett J, Hunt PW, Martin JN, Haberer JE, Bangsberg DR. PMID: 24361683.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    114. Higher CD27+CD8+ T cells percentages during suppressive antiretroviral therapy predict greater subsequent CD4+ T cell recovery in treated HIV infection. PLoS One. 2013; 8(12):e84091. Seu L, Ortiz GM, Epling L, Sinclair E, Swainson LA, Bajpai UD, Huang Y, Deeks SG, Hunt PW, Martin JN, McCune JM. PMID: 24391889.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    115. CD56negCD16? NK cells are activated mature NK cells with impaired effector function during HIV-1 infection. Retrovirology. 2013 Dec 18; 10:158. Milush JM, López-Vergès S, York VA, Deeks SG, Martin JN, Hecht FM, Lanier LL, Nixon DF. PMID: 24351015.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    116. Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda. Ann Behav Med. 2013 Dec; 46(3):285-94. Tsai AC, Bangsberg DR, Kegeles SM, Katz IT, Haberer JE, Muzoora C, Kumbakumba E, Hunt PW, Martin JN, Weiser SD. PMID: 23690283.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    117. HIV antibody characterization as a method to quantify reservoir size during curative interventions. J Infect Dis. 2014 May 15; 209(10):1613-7. Burbelo PD, Bayat A, Rhodes CS, Hoh R, Martin JN, Fromentin R, Chomont N, Hütter G, Kovacs JA, Deeks SG. PMID: 24286982.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    118. Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. PLoS One. 2013; 8(11):e78952. Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Collier A, Samji H, Thorne JE, Althoff KN, Martin JN, Rodriguez B, Stuart EA, Gange SJ, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epi . PMID: 24260137.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    119. Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers. AIDS. 2013 Nov 13; 27(17):2691-6. Asher AK, Santos GM, Evans J, Dokubo EK, Lee TH, Martin JN, Deeks SG, Tobler LH, Busch M, Hunt PW, Page K. PMID: 23939233.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    120. Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survival. Ann Thorac Surg. 2014 Jan; 97(1):230-5. Berry MF, Worni M, Wang X, Harpole DH, D'Amico TA, Onaitis MW. PMID: 24220289.
      View in: PubMed   Mentions:
    121. Measuring the overall genetic component of nevirapine pharmacokinetics and the role of selected polymorphisms: towards addressing the missing heritability in pharmacogenetic phenotypes? Pharmacogenet Genomics. 2013 Nov; 23(11):591-6. Micheli JE, Chinn LW, Shugarts SB, Patel A, Martin JN, Bangsberg DR, Kroetz DL. PMID: 23982262.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    122. Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. PLoS Pathog. 2013; 9(10):e1003691. Hatano H, Yukl SA, Ferre AL, Graf EH, Somsouk M, Sinclair E, Abdel-Mohsen M, Liegler T, Harvill K, Hoh R, Palmer S, Bacchetti P, Hunt PW, Martin JN, McCune JM, Tracy RP, Busch MP, O'Doherty U, Shacklett BL, Wong JK, Deeks SG. PMID: 24130489.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCellsCTClinical Trials
    123. Self-reported alcohol abstinence associated with ART initiation among HIV-infected persons in rural Uganda. Drug Alcohol Depend. 2014 Jan 01; 134:151-157. Santos GM, Emenyonu NI, Bajunirwe F, Rain Mocello A, Martin JN, Vittinghoff E, Bangsberg DR, Hahn JA. PMID: 24169501.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    124. HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods. AIDS. 2013 Oct; 27 Suppl 1:S105-12. Matthews LT, Kaida A, Kanters S, Byakwagamd H, Mocello AR, Muzoora C, Kembabazi A, Haberer JE, Martin JN, Bangsberg DR, Hunt PW. PMID: 24088676.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    125. How does antiretroviral treatment attenuate the stigma of HIV? Evidence from a cohort study in rural Uganda. AIDS Behav. 2013 Oct; 17(8):2725-31. Tsai AC, Bangsberg DR, Bwana M, Haberer JE, Frongillo EA, Muzoora C, Kumbakumba E, Hunt PW, Martin JN, Weiser SD. PMID: 23670710.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    126. Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers. AIDS. 2013 Sep 10; 27(14):2255-60. Hatano H, Somsouk M, Sinclair E, Harvill K, Gilman L, Cohen M, Hoh R, Hunt PW, Martin JN, Wong JK, Deeks SG, Yukl SA. PMID: 24157906.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    127. Realtime adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda. AIDS. 2013 Aug 24; 27(13):2166-8. Haberer JE, Kiwanuka J, Nansera D, Muzoora C, Hunt PW, So J, O'Donnell M, Siedner M, Martin JN, Bangsberg DR. PMID: 23751260.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    128. Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial. J Infect Dis. 2013 Nov 01; 208(9):1436-42. Hatano H, Strain MC, Scherzer R, Bacchetti P, Wentworth D, Hoh R, Martin JN, McCune JM, Neaton JD, Tracy RP, Hsue PY, Richman DD, Deeks SG. PMID: 23975885.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansCells
    129. Gag-positive reservoir cells are susceptible to HIV-specific cytotoxic T lymphocyte mediated clearance in vitro and can be detected in vivo [corrected]. PLoS One. 2013; 8(8):e71879. Graf EH, Pace MJ, Peterson BA, Lynch LJ, Chukwulebe SB, Mexas AM, Shaheen F, Martin JN, Deeks SG, Connors M, Migueles SA, O'Doherty U. PMID: 23951263.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    130. AIDS alters the commensal plasma virome. J Virol. 2013 Oct; 87(19):10912-5. Li L, Deng X, Linsuwanon P, Bangsberg D, Bwana MB, Hunt P, Martin JN, Deeks SG, Delwart E. PMID: 23903845.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    131. Disinhibition in risky sexual behavior in men, but not women, during four years of antiretroviral therapy in rural, southwestern Uganda. PLoS One. 2013; 8(7):e69634. Kembabazi A, Bajunirwe F, Hunt PW, Martin JN, Muzoora C, Haberer JE, Bangsberg DR, Siedner MJ. PMID: 23894514.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    132. Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection. AIDS. 2013 Jul 17; 27(11):1735-42. Unemori P, Leslie KS, Hunt PW, Sinclair E, Epling L, Mitsuyasu R, Effros RB, Dock J, Dollard SG, Deeks SG, Martin JN, Maurer TA. PMID: 23435301.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    133. High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010. . 2013 Jul 01; 63(3):299-306. Dombrowski JC, Kitahata MM, Van Rompaey SE, Crane HM, Mugavero MJ, Eron JJ, Boswell SL, Rodriguez B, Mathews WC, Martin JN, Moore RD, Golden MR. PMID: 23572013.
      View in: PubMed   Mentions:
    134. Correction: Incidence and Predictors of Pregnancy among a Cohort of HIV-Positive Women Initiating Antiretroviral Therapy in Mbarara, Uganda. PLoS One. 2013; 8(6). Kaida A, Matthews LT, Kanters S, Kabakyenga J, Muzoora C, Mocello AR, Martin JN, Hunt P, Haberer J, Hogg RS, Bangsberg DR. PMID: 29161730.
      View in: PubMed   Mentions:    Fields:    
    135. GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda. AIDS. 2013 Jun 01; 27(9):1503-8. Siedner MJ, Lankowski A, Tsai AC, Muzoora C, Martin JN, Hunt PW, Haberer JE, Bangsberg DR. PMID: 23435294.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    136. Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda. . 2013 Jun 01; 63(2):e64-71. Geng EH, Bwana MB, Muyindike W, Glidden DV, Bangsberg DR, Neilands TB, Bernheimer I, Musinguzi N, Yiannoutsos CT, Martin JN. PMID: 23429504.
      View in: PubMed   Mentions:
    137. Incidence and predictors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara, Uganda. PLoS One. 2013; 8(5):e63411. Kaida A, Matthews LT, Kanters S, Kabakyenga J, Muzoora C, Mocello AR, Martin JN, Hunt P, Haberer J, Hogg RS, Bangsberg DR. PMID: 23704906.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    138. Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individuals. Atherosclerosis. 2013 Jul; 229(1):246-52. Parikh RV, Scherzer R, Grunfeld C, Nitta EM, Leone A, Martin JN, Deeks SG, Ganz P, Hsue PY. PMID: 23711612.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    139. The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial. Blood. 2013 Jun 06; 121(23):4635-46. Hunt PW, Shulman NS, Hayes TL, Dahl V, Somsouk M, Funderburg NT, McLaughlin B, Landay AL, Adeyemi O, Gilman LE, Clagett B, Rodriguez B, Martin JN, Schacker TW, Shacklett BL, Palmer S, Lederman MM, Deeks SG. PMID: 23589670.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCells
    140. T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques. J Virol. 2013 Jun; 87(11):6073-80. Champiat S, Garrison KE, Raposo RA, Burwitz BJ, Reed J, Tandon R, York VA, Newman LP, Nimityongskul FA, Wilson NA, Almeida RR, Martin JN, Deeks SG, Rosenberg MG, Wiznia AA, Spotts GE, Pilcher CD, Hecht FM, Ostrowski MA, Sacha JB, Nixon DF. PMID: 23536679.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    141. Dissemination of research findings to research participants living with HIV in rural Uganda: challenges and rewards. PLoS Med. 2013; 10(3):e1001397. Baylor A, Muzoora C, Bwana M, Kembabazi A, Haberer JE, Matthews LT, Tsai AC, Hunt PW, Martin JN, Bangsberg DR. PMID: 23472055.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    142. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis. 2013 Apr; 56(8):1174-82. Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Lau B, Althoff KN, Crane HM, Collier AC, Samji H, Thorne JE, Gill MJ, Klein MB, Martin JN, Rodriguez B, Rourke SB, Gange SJ, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epi . PMID: 23315317.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    143. Evidence for the reliability and validity of the internalized AIDS-related stigma scale in rural Uganda. AIDS Behav. 2013 Jan; 17(1):427-33. Tsai AC, Weiser SD, Steward WT, Mukiibi NF, Kawuma A, Kembabazi A, Muzoora C, Hunt PW, Martin JN, Bangsberg DR. PMID: 22869104.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    144. No association found between traditional healer use and delayed antiretroviral initiation in rural Uganda. AIDS Behav. 2013 Jan; 17(1):260-5. Horwitz RH, Tsai AC, Maling S, Bajunirwe F, Haberer JE, Emenyonu N, Muzoora C, Hunt PW, Martin JN, Bangsberg DR. PMID: 22246516.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    145. Sexual relationship power and depression among HIV-infected women in Rural Uganda. PLoS One. 2012; 7(12):e49821. Hatcher AM, Tsai AC, Kumbakumba E, Dworkin SL, Hunt PW, Martin JN, Clark G, Bangsberg DR, Weiser SD. PMID: 23300519.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    146. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood. 2013 Feb 14; 121(7):1124-35. Leeansyah E, Ganesh A, Quigley MF, Sönnerborg A, Andersson J, Hunt PW, Somsouk M, Deeks SG, Martin JN, Moll M, Shacklett BL, Sandberg JK. PMID: 23243281.
      View in: PubMed   Mentions: 149     Fields:    Translation:HumansCells
    147. Differential expression of CD96 surface molecule represents CD8? T cells with dissimilar effector function during HIV-1 infection. PLoS One. 2012; 7(12):e51696. Eriksson EM, Keh CE, Deeks SG, Martin JN, Hecht FM, Nixon DF. PMID: 23272144.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    148. Lack of evidence for mtDNA as a biomarker of innate immune activation in HIV infection. PLoS One. 2012; 7(11):e50486. Lauring AS, Lee TH, Martin JN, Hunt PW, Deeks SG, Busch M. PMID: 23209754.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    149. The activity of the integrase inhibitor dolutegravir against HIV-1 variants isolated from raltegravir-treated adults. . 2012 Nov 01; 61(3):297-301. Underwood MR, Johns BA, Sato A, Martin JN, Deeks SG, Fujiwara T. PMID: 22878423.
      View in: PubMed   Mentions:
    150. A randomized controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infection. . 2012 Nov 01; 61(3):317-25. Hatano H, Scherzer R, Wu Y, Harvill K, Maka K, Hoh R, Sinclair E, Palmer S, Martin JN, Busch MP, Deeks SG, Hsue PY. PMID: 22918156.
      View in: PubMed   Mentions:
    151. Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. J Infect Dis. 2013 Jul; 208(1):50-6. Hatano H, Jain V, Hunt PW, Lee TH, Sinclair E, Do TD, Hoh R, Martin JN, McCune JM, Hecht F, Busch MP, Deeks SG. PMID: 23089590.
      View in: PubMed   Mentions: 131     Fields:    Translation:HumansCells
    152. Contraceptive use and associated factors among women enrolling into HIV care in southwestern Uganda. Infect Dis Obstet Gynecol. 2012; 2012:340782. Muyindike W, Fatch R, Steinfield R, Matthews LT, Musinguzi N, Emenyonu NI, Martin JN, Hahn JA. PMID: 23082069.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    153. Changes in food insecurity, nutritional status, and physical health status after antiretroviral therapy initiation in rural Uganda. . 2012 Oct 01; 61(2):179-86. Weiser SD, Gupta R, Tsai AC, Frongillo EA, Grede N, Kumbakumba E, Kawuma A, Hunt PW, Martin JN, Bangsberg DR. PMID: 22692093.
      View in: PubMed   Mentions:
    154. Optimizing network connectivity for mobile health technologies in sub-Saharan Africa. PLoS One. 2012; 7(9):e45643. Siedner MJ, Lankowski A, Musinga D, Jackson J, Muzoora C, Hunt PW, Martin JN, Bangsberg DR, Haberer JE. PMID: 23029155.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    155. Prolonged and substantial discordance in prevalence of raltegravir-resistant HIV-1 in plasma versus PBMC samples revealed by 454 "deep" sequencing. PLoS One. 2012; 7(9):e46181. Lee GQ, Swenson LC, Poon AF, Martin JN, Hatano H, Deeks SG, Harrigan PR. PMID: 23049972.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    156. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS. 2012 Sep 24; 26(15):1907-15. Kalayjian RC, Lau B, Mechekano RN, Crane HM, Rodriguez B, Salata RA, Krishnasami Z, Willig JH, Martin JN, Moore RD, Eron JJ, Kitahata MM. PMID: 22824630.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    157. Doppler echocardiography does not accurately estimate pulmonary artery systolic pressure in HIV-infected patients. AIDS. 2012 Sep 24; 26(15):1967-9. Selby VN, Scherzer R, Barnett CF, MacGregor JS, Morelli J, Donovan C, Deeks SG, Martin JN, Hsue PY. PMID: 22781217.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    158. Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings. Curr Opin Oncol. 2012 Sep; 24(5):522-30. Semeere AS, Busakhala N, Martin JN. PMID: 22729153.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    159. Prevalence and significance of HIV-1 drug resistance mutations among patients on antiretroviral therapy with detectable low-level viremia. Antimicrob Agents Chemother. 2012 Nov; 56(11):5998-6000. Li JZ, Gallien S, Do TD, Martin JN, Deeks S, Kuritzkes DR, Hatano H. PMID: 22890763.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    160. Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection. PLoS One. 2012; 7(8):e41021. Ormsby CE, Sengupta D, Tandon R, Deeks SG, Martin JN, Jones RB, Ostrowski MA, Garrison KE, Vázquez-Pérez JA, Reyes-Terán G, Nixon DF. PMID: 22879884.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    161. Sexual relationship power and malnutrition among HIV-positive women in rural Uganda. AIDS Behav. 2012 Aug; 16(6):1542-8. Siedner MJ, Tsai AC, Dworkin S, Mukiibi NF, Emenyonu NI, Hunt PW, Haberer JE, Martin JN, Bangsberg DR, Weiser SD. PMID: 22382629.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    162. Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection. PLoS One. 2012; 7(6):e39311. Champiat S, Raposo RA, Maness NJ, Lehman JL, Purtell SE, Hasenkrug AM, Miller JC, Dean H, Koff WC, Hong MA, Martin JN, Deeks SG, Spotts GE, Pilcher CD, Hecht FM, Kallas EG, Garrison KE, Nixon DF. PMID: 22768072.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    163. Rethinking the "pre" in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs. PLoS One. 2012; 7(6):e39894. Siedner MJ, Lankowski A, Haberer JE, Kembabazi A, Emenyonu N, Tsai AC, Muzoora C, Geng E, Martin JN, Bangsberg DR. PMID: 22761924.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    164. The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease. AIDS. 2012 Jun 01; 26(9):1115-20. Ho JE, Scherzer R, Hecht FM, Maka K, Selby V, Martin JN, Ganz P, Deeks SG, Hsue PY. PMID: 22382147.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    165. A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis. AIDS. 2012 Apr 24; 26(7):805-14. Sacre K, Hunt PW, Hsue PY, Maidji E, Martin JN, Deeks SG, Autran B, McCune JM. PMID: 22313962.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    166. Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation. J Am Heart Assoc. 2012 Apr; 1(2). Hsue PY, Scherzer R, Hunt PW, Schnell A, Bolger AF, Kalapus SC, Maka K, Martin JN, Ganz P, Deeks SG. PMID: 23130122.
      View in: PubMed   Mentions: 50     Fields:    
    167. HIV infection is associated with decreased thrombin generation. Clin Infect Dis. 2012 Apr; 54(8):1196-203. Hsue PY, Scherzer R, Grunfeld C, Nordstrom SM, Schnell A, Kohl LP, Nitta E, Martin JN, Deeks SG, Weiss EJ. PMID: 22438347.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    168. Food insecurity, depression and the modifying role of social support among people living with HIV/AIDS in rural Uganda. Soc Sci Med. 2012 Jun; 74(12):2012-9. Tsai AC, Bangsberg DR, Frongillo EA, Hunt PW, Muzoora C, Martin JN, Weiser SD. PMID: 22513248.
      View in: PubMed   Mentions: 140     Fields:    Translation:Humans
    169. Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease. PLoS Genet. 2012 Feb; 8(2):e1002514. Chen H, Hayashi G, Lai OY, Dilthey A, Kuebler PJ, Wong TV, Martin MP, Fernandez Vina MA, McVean G, Wabl M, Leslie KS, Maurer T, Martin JN, Deeks SG, Carrington M, Bowcock AM, Nixon DF, Liao W. PMID: 22577363.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    170. A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa. Am J Epidemiol. 2012 May 15; 175(10):1080-7. Geng EH, Glidden DV, Bangsberg DR, Bwana MB, Musinguzi N, Nash D, Metcalfe JZ, Yiannoutsos CT, Martin JN, Petersen ML. PMID: 22306557.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    171. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis. 2012 Apr; 54(7):1026-34. Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, Goedert JJ, Kirk GD, D'Souza G, Bosch RJ, Brooks JT, Napravnik S, Hessol NA, Jacobson LP, Kitahata MM, Klein MB, Moore RD, Rodriguez B, Rourke SB, Saag MS, Sterling TR, Gebo KA, Press N, Martin JN, Dubrow R, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA . PMID: 22291097.
      View in: PubMed   Mentions: 163     Fields:    Translation:Humans
    172. Food insecurity is associated with morbidity and patterns of healthcare utilization among HIV-infected individuals in a resource-poor setting. AIDS. 2012 Jan 02; 26(1):67-75. Weiser SD, Tsai AC, Gupta R, Frongillo EA, Kawuma A, Senkungu J, Hunt PW, Emenyonu NI, Mattson JE, Martin JN, Bangsberg DR. PMID: 21904186.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansCells
    173. Increased CD34+/KDR+ cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjects. Antivir Ther. 2012; 17(3):557-63. Papasavvas E, Hsue P, Reynolds G, Pistilli M, Hancock A, Martin JN, Deeks SG, Montaner LJ. PMID: 22300770.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    174. Epistatic interactions between Fc (GM) and Fc?R genes and the host control of human immunodeficiency virus replication. Hum Immunol. 2012 Mar; 73(3):263-6. Deepe RN, Kistner-Griffin E, Martin JN, Deeks SG, Pandey JP. PMID: 22213007.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    175. Carotid intima-media thickness among human immunodeficiency virus-infected patients without coronary calcium. Am J Cardiol. 2012 Mar 01; 109(5):742-7. Hsue PY, Ordovas K, Lee T, Reddy G, Gotway M, Schnell A, Ho JE, Selby V, Madden E, Martin JN, Deeks SG, Ganz P, Waters DD. PMID: 22169125.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    176. Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity. Blood. 2012 Jan 19; 119(3):745-55. Eriksson EM, Milush JM, Ho EL, Batista MD, Holditch SJ, Keh CE, Norris PJ, Keating SM, Deeks SG, Hunt PW, Martin JN, Rosenberg MG, Hecht FM, Nixon DF. PMID: 22134167.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    177. Plasma components affect accuracy of circulating cancer-related microRNA quantitation. J Mol Diagn. 2012 Jan; 14(1):71-80. Kim DJ, Linnstaedt S, Palma J, Park JC, Ntrivalas E, Kwak-Kim JY, Gilman-Sachs A, Beaman K, Hastings ML, Martin JN, Duelli DM. PMID: 22154918.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    178. Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS. 2011 Nov 13; 25(17):2123-31. Hunt PW, Cao HL, Muzoora C, Ssewanyana I, Bennett J, Emenyonu N, Kembabazi A, Neilands TB, Bangsberg DR, Deeks SG, Martin JN. PMID: 21881481.
      View in: PubMed   Mentions: 128     Fields:    Translation:HumansCells
    179. Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America. PLoS Med. 2011 Oct; 8(10):e1001111. Chi BH, Yiannoutsos CT, Westfall AO, Newman JE, Zhou J, Cesar C, Brinkhof MW, Mwango A, Balestre E, Carriquiry G, Sirisanthana T, Mukumbi H, Martin JN, Grimsrud A, Bacon M, Thiebaut R, International Epidemiologic Databases to Evaluate AIDS Collaboration . PMID: 22039357.
      View in: PubMed   Mentions: 100     Fields:    Translation:HumansCells
    180. The social context of food insecurity among persons living with HIV/AIDS in rural Uganda. Soc Sci Med. 2011 Dec; 73(12):1717-24. Tsai AC, Bangsberg DR, Emenyonu N, Senkungu JK, Martin JN, Weiser SD. PMID: 22019367.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    181. Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009. J Int AIDS Soc. 2011 Sep 28; 14:46. Geng EH, Hunt PW, Diero LO, Kimaiyo S, Somi GR, Okong P, Bangsberg DR, Bwana MB, Cohen CR, Otieno JA, Wabwire D, Elul B, Nash D, Easterbrook PJ, Braitstein P, Musick BS, Martin JN, Yiannoutsos CT, Wools-Kaloustian K. PMID: 21955541.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    182. Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. J Infect Dis. 2011 Sep 15; 204(6):893-901. Sterling TR, Lau B, Zhang J, Freeman A, Bosch RJ, Brooks JT, Deeks SG, French A, Gange S, Gebo KA, John Gill M, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Klein MB, Martin JN, Rodriguez B, Silverberg MJ, Willig JH, Eron JJ, Goedert JJ, Hogg RS, Justice AC, McKaig RG, Napravnik S, Thorne J, Moore RD, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epi . PMID: 21849286.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    183. Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approach. PLoS One. 2011; 6(7):e21797. Geng EH, Glidden DV, Bwana MB, Musinguzi N, Emenyonu N, Muyindike W, Christopoulos KA, Neilands TB, Yiannoutsos CT, Deeks SG, Bangsberg DR, Martin JN. PMID: 21818265.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    184. A randomized noninferiority trial of standard versus enhanced risk reduction and adherence counseling for individuals receiving post-exposure prophylaxis following sexual exposures to HIV. Clin Infect Dis. 2011 Jul 01; 53(1):76-83. Roland ME, Neilands TB, Krone MR, Coates TJ, Franses K, Chesney MA, Kahn JS, Martin JN. PMID: 21653307.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    185. Pulmonary hypertension in HIV-infected individuals. Clin Infect Dis. 2011 Jul 01; 53(1):96; author reply 96-7. Hsue PY, Bolger AF, Martin JN. PMID: 21653312.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    186. Immune activation, CD4+ T cell counts, and viremia exhibit oscillatory patterns over time in patients with highly resistant HIV infection. PLoS One. 2011; 6(6):e21190. Kitchen CM, Yeghiazarian L, Hoh R, McCune JM, Sinclair E, Martin JN, Deeks SG. PMID: 21701594.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    187. Human endogenous retrovirus K106 (HERV-K106) was infectious after the emergence of anatomically modern humans. PLoS One. 2011; 6(5):e20234. Jha AR, Nixon DF, Rosenberg MG, Martin JN, Deeks SG, Hudson RR, Garrison KE, Pillai SK. PMID: 21633511.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    188. Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J Infect Dis. 2011 May 15; 203(10):1474-83. Hunt PW, Martin JN, Sinclair E, Epling L, Teague J, Jacobson MA, Tracy RP, Corey L, Deeks SG. PMID: 21502083.
      View in: PubMed   Mentions: 158     Fields:    Translation:HumansCells
    189. Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection. J Virol. 2011 Jul; 85(14):6977-85. SenGupta D, Tandon R, Vieira RG, Ndhlovu LC, Lown-Hecht R, Ormsby CE, Loh L, Jones RB, Garrison KE, Martin JN, York VA, Spotts G, Reyes-Terán G, Ostrowski MA, Hecht FM, Deeks SG, Nixon DF. PMID: 21525339.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    190. A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response. J Infect Dis. 2011 Apr 01; 203(7):960-8. Hatano H, Hayes TL, Dahl V, Sinclair E, Lee TH, Hoh R, Lampiris H, Hunt PW, Palmer S, McCune JM, Martin JN, Busch MP, Shacklett BL, Deeks SG. PMID: 21402547.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansCells
    191. Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression. Blood. 2011 Apr 07; 117(14):3799-808. Hersperger AR, Martin JN, Shin LY, Sheth PM, Kovacs CM, Cosma GL, Makedonas G, Pereyra F, Walker BD, Kaul R, Deeks SG, Betts MR. PMID: 21289310.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansCells
    192. A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS One. 2011 Jan 31; 6(1):e15924. Hunt PW, Landay AL, Sinclair E, Martinson JA, Hatano H, Emu B, Norris PJ, Busch MP, Martin JN, Brooks C, McCune JM, Deeks SG. PMID: 21305005.
      View in: PubMed   Mentions: 67     Fields:    Translation:Cells
    193. Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons. Clin Infect Dis. 2011 Apr 01; 52(7):941-4. Choi AI, Lo JC, Mulligan K, Schnell A, Kalapus SC, Li Y, Hunt PW, Martin JN, Deeks SG, Hsue PY. PMID: 21273298.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    194. HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers. Clin Infect Dis. 2011 Mar 01; 52(5):681-7. Hunt PW, Hatano H, Sinclair E, Lee TH, Busch MP, Martin JN, McCune JM, Deeks SG. PMID: 21245154.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    195. HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells. Blood. 2011 Feb 17; 117(7):2189-99. Favre D, Stoddart CA, Emu B, Hoh R, Martin JN, Hecht FM, Deeks SG, McCune JM. PMID: 21200021.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    196. CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation? AIDS Res Ther. 2010 Dec 15; 7:45. Althoff KN, Gebo KA, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Eron JJ, Napravnik S, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Deeks SG, Martin JN, Jacobson LP, Kirk GD, Collier AC, Benson CA, Silverberg MJ, Goedert JJ, McKaig RG, Thorne J, Rachlis A, Moore RD, Justice AC, North American AIDS Cohort Collaboration on Research and Design . PMID: 21159161.
      View in: PubMed   Mentions: 29     Fields:    
    197. Biomarker testing to estimate under-reported heavy alcohol consumption by persons with HIV initiating ART in Uganda. AIDS Behav. 2010 Dec; 14(6):1265-8. Hahn JA, Bwana MB, Javors MA, Martin JN, Emenyonu NI, Bangsberg DR. PMID: 20697796.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    198. Diminishing availability of publicly funded slots for antiretroviral initiation among HIV-infected ART-eligible patients in Uganda. PLoS One. 2010 Nov 24; 5(11):e14098. Geng EH, Bwana MB, Kabakyenga J, Muyindike W, Emenyonu NI, Musinguzi N, Mugyenyi P, Martin JN, Bangsberg DR. PMID: 21124842.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    199. Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt". Int J Cancer. 2010 Nov 15; 127(10):2395-401. Dollard SC, Butler LM, Jones AM, Mermin JH, Chidzonga M, Chipato T, Shiboski CH, Brander C, Mosam A, Kiepiela P, Hladik W, Martin JN. PMID: 20143397.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    200. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010 Dec 10; 330(6010):1551-7. International HIV Controllers Study , Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N, Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H, Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE, Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch C, Bodner SJ, Bolan RK, Boudreaux ET, Bradley M, Braun JF, Brndjar JE, Brown SJ, Brown K, Brown ST, Burack J, Bush LM, Cafaro V, Campbell O, Campbell J, Carlson RH, Carmichael JK, Casey KK, Cavacuiti C, Celestin G, Chambers ST, Chez N, Chirch LM, Cimoch PJ, Cohen D, Cohn LE, Conway B, Cooper DA, Cornelson B, Cox DT, Cristofano MV, Cuchural G, Czartoski JL, Dahman JM, Daly JS, Davis BT, Davis K, Davod SM, DeJesus E, Dietz CA, Dunham E, Dunn ME, Ellerin TB, Eron JJ, Fangman JJ, Farel CE, Ferlazzo H, Fidler S, Fleenor-Ford A, Frankel R, Freedberg KA, French NK, Fuchs JD, Fuller JD, Gaberman J, Gallant JE, Gandhi RT, Garcia E, Garmon D, Gathe JC, Gaultier CR, Gebre W, Gilman FD, Gilson I, Goepfert PA, Gottlieb MS, Goulston C, Groger RK, Gurley TD, Haber S, Hardwicke R, Hardy WD, Harrigan PR, Hawkins TN, Heath S, Hecht FM, Henry WK, Hladek M, Hoffman RP, Horton JM, Hsu RK, Huhn GD, Hunt P, Hupert MJ, Illeman ML, Jaeger H, Jellinger RM, John M, Johnson JA, Johnson KL, Johnson H, Johnson K, Joly J, Jordan WC, Kauffman CA, Khanlou H, Killian RK, Kim AY, Kim DD, Kinder CA, Kirchner JT, Kogelman L, Kojic EM, Korthuis PT, Kurisu W, Kwon DS, LaMar M, Lampiris H, Lanzafame M, Lederman MM, Lee DM, Lee JM, Lee MJ, Lee ET, Lemoine J, Levy JA, Llibre JM, Liguori MA, Little SJ, Liu AY, Lopez AJ, Loutfy MR, Loy D, Mohammed DY, Man A, Mansour MK, Marconi VC, Markowitz M, Marques R, Martin JN, Martin HL, Mayer KH, McElrath MJ, McGhee TA, McGovern BH, McGowan K, McIntyre D, Mcleod GX, Menezes P, Mesa G, Metroka CE, Meyer-Olson D, Miller AO, Montgomery K, Mounzer KC, Nagami EH, Nagin I, Nahass RG, Nelson MO, Nielsen C, Norene DL, O'Connor DH, Ojikutu BO, Okulicz J, Oladehin OO, Oldfield EC, Olender SA, Ostrowski M, Owen WF, Pae E, Parsonnet J, Pavlatos AM, Perlmutter AM, Pierce MN, Pincus JM, Pisani L, Price LJ, Proia L, Prokesch RC, Pujet HC, Ramgopal M, Rathod A, Rausch M, Ravishankar J, Rhame FS, Richards CS, Richman DD, Rodes B, Rodriguez M, Rose RC, Rosenberg ES, Rosenthal D, Ross PE, Rubin DS, Rumbaugh E, Saenz L, Salvaggio MR, Sanchez WC, Sanjana VM, Santiago S, Schmidt W, Schuitemaker H, Sestak PM, Shalit P, Shay W, Shirvani VN, Silebi VI, Sizemore JM, Skolnik PR, Sokol-Anderson M, Sosman JM, Stabile P, Stapleton JT, Starrett S, Stein F, Stellbrink HJ, Sterman FL, Stone VE, Stone DR, Tambussi G, Taplitz RA, Tedaldi EM, Telenti A, Theisen W, Torres R, Tosiello L, Tremblay C, Tribble MA, Trinh PD, Tsao A, Ueda P, Vaccaro A, Valadas E, Vanig TJ, Vecino I, Vega VM, Veikley W, Wade BH, Walworth C, Wanidworanun C, Ward DJ, Warner DA, Weber RD, Webster D, Weis S, Wheeler DA, White DJ, Wilkins E, Winston A, Wlodaver CG, van't Wout A, Wright DP, Yang OO, Yurdin DL, Zabukovic BW, Zachary KC, Zeeman B, Zhao M. PMID: 21051598.
      View in: PubMed   Mentions: 577     Fields:    Translation:HumansCells
    201. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010 Nov; 7(4):234-44. Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, Christopoulos KA, Muyindike W, Bwana MB, Yiannoutsos CT, Petersen ML, Martin JN. PMID: 20820972.
      View in: PubMed   Mentions: 140     Fields:    Translation:Humans
    202. Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals. AIDS. 2010 Oct 23; 24(16):2535-9. Hatano H, Delwart EL, Norris PJ, Lee TH, Neilands TB, Kelley CF, Hunt PW, Hoh R, Linnen JM, Martin JN, Busch MP, Deeks SG. PMID: 20651585.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    203. HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses. J Virol. 2010 Nov; 84(21):11020-9. Ferre AL, Hunt PW, McConnell DH, Morris MM, Garcia JC, Pollard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL. PMID: 20719952.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    204. Intracellular Casp8p41 content is inversely associated with CD4 T cell count. J Infect Dis. 2010 Aug 15; 202(3):386-91. Cummins NW, Jiang W, McGinty J, Bren GD, Bosch RJ, Landay A, Deeks SG, Martin JN, Douek D, Lederman MM, Brenchley J, Badley AD. PMID: 20565257.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    205. A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5. J Virol. 2010 Oct; 84(20):10863-76. Tilton JC, Wilen CB, Didigu CA, Sinha R, Harrison JE, Agrawal-Gamse C, Henning EA, Bushman FD, Martin JN, Deeks SG, Doms RW. PMID: 20702642.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    206. Evolution of integrase resistance during failure of integrase inhibitor-based antiretroviral therapy. . 2010 Aug; 54(4):389-93. Hatano H, Lampiris H, Fransen S, Gupta S, Huang W, Hoh R, Martin JN, Lalezari J, Bangsberg D, Petropoulos C, Deeks SG. PMID: 20300008.
      View in: PubMed   Mentions:
    207. Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals. AIDS. 2010 Jul 31; 24(12):1897-905. Ho JE, Deeks SG, Hecht FM, Xie Y, Schnell A, Martin JN, Ganz P, Hsue PY. PMID: 20543654.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    208. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers. J Virol. 2010 Oct; 84(19):10354-65. Ferre AL, Lemongello D, Hunt PW, Morris MM, Garcia JC, Pollard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL. PMID: 20668079.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    209. Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa. Trop Med Int Health. 2010 Jun; 15 Suppl 1:63-9. Geng EH, Glidden DV, Emenyonu N, Musinguzi N, Bwana MB, Neilands TB, Muyindike W, Yiannoutsos CT, Deeks SG, Bangsberg DR, Martin JN. PMID: 20586962.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    210. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis. 2010 Jun 01; 50(11):1512-20. Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Justice AC, Gebo KA, Eron JJ, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Calzavara LM, Deeks SG, Martin JN, Rachlis AR, Napravnik S, Jacobson LP, Kirk GD, Collier AC, Benson CA, Silverberg MJ, Kushel M, Goedert JJ, McKaig RG, Van Rompaey SE, Zhang J, Moore RD. PMID: 20415573.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    211. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med. 2010 May 19; 2(32):32ra36. Favre D, Mold J, Hunt PW, Kanwar B, Loke P, Seu L, Barbour JD, Lowe MM, Jayawardene A, Aweeka F, Huang Y, Douek DC, Brenchley JM, Martin JN, Hecht FM, Deeks SG, McCune JM. PMID: 20484731.
      View in: PubMed   Mentions: 245     Fields:    Translation:HumansCells
    212. HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses. AIDS. 2010 May 15; 24(8):1095-105. Owen RE, Heitman JW, Hirschkorn DF, Lanteri MC, Biswas HH, Martin JN, Krone MR, Deeks SG, Norris PJ, NIAID Center for HIV/AIDS Vaccine Immunology . PMID: 20400885.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    213. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. . 2010 Mar; 53(3):405-11. Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, Yiannoutsos CT, Glidden DV, Deeks SG, Martin JN. PMID: 19745753.
      View in: PubMed   Mentions:
    214. Correlating cellular and molecular signatures of mucosal immunity that distinguish HIV controllers from noncontrollers. Blood. 2010 Apr 15; 115(15):e20-32. Loke P, Favre D, Hunt PW, Leung JM, Kanwar B, Martin JN, Deeks SG, McCune JM. PMID: 20160163.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    215. Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease. PLoS One. 2010 Jan 29; 5(1):e8886. Naeger DM, Martin JN, Sinclair E, Hunt PW, Bangsberg DR, Hecht F, Hsue P, McCune JM, Deeks SG. PMID: 20126452.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansCells
    216. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet. 2009 Dec; 41(12):1290-4. Thomas R, Apps R, Qi Y, Gao X, Male V, O'hUigin C, O'Connor G, Ge D, Fellay J, Martin JN, Margolick J, Goedert JJ, Buchbinder S, Kirk GD, Martin MP, Telenti A, Deeks SG, Walker BD, Goldstein D, McVicar DW, Moffett A, Carrington M. PMID: 19935663.
      View in: PubMed   Mentions: 142     Fields:    Translation:Humans
    217. Impact of HIV infection on diastolic function and left ventricular mass. Circ Heart Fail. 2010 Jan; 3(1):132-9. Hsue PY, Hunt PW, Ho JE, Farah HH, Schnell A, Hoh R, Martin JN, Deeks SG, Bolger AF. PMID: 19933410.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    218. Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis. 2009 Nov 15; 49(10):1582-90. Deeks SG, Gange SJ, Kitahata MM, Saag MS, Justice AC, Hogg RS, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Benson CA, Collier AC, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Kushel MB, Goedert JJ, McKaig RG, Moore RD. PMID: 19845473.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    219. HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy. AIDS. 2009 Oct 23; 23(16):2143-9. Choi AI, Shlipak MG, Hunt PW, Martin JN, Deeks SG. PMID: 19684507.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    220. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. . 2009 Oct 01; 52(2):280-9. Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, Bangsberg DR, Hahn JA. PMID: 19521248.
      View in: PubMed   Mentions:
    221. Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients. AIDS. 2009 Sep 24; 23(15):2021-7. Hsue PY, Hunt PW, Wu Y, Schnell A, Ho JE, Hatano H, Xie Y, Martin JN, Ganz P, Deeks SG. PMID: 19542863.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    222. Cross-sectional dating of novel haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa before Homo sapiens. Mol Biol Evol. 2009 Nov; 26(11):2617-26. Jha AR, Pillai SK, York VA, Sharp ER, Storm EC, Wachter DJ, Martin JN, Deeks SG, Rosenberg MG, Nixon DF, Garrison KE. PMID: 19666991.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    223. Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission. J Infect Dis. 2009 Aug 01; 200(3):430-8. Butler LM, Dorsey G, Hladik W, Rosenthal PJ, Brander C, Neilands TB, Mbisa G, Whitby D, Kiepiela P, Mosam A, Mzolo S, Dollard SC, Martin JN. PMID: 19534596.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    224. Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses. Clin Vaccine Immunol. 2009 Sep; 16(9):1369-71. Garrison KE, Champiat S, York VA, Agrawal AT, Kallas EG, Martin JN, Hecht FM, Deeks SG, Nixon DF. PMID: 19571107.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    225. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS. 2009 Jun 01; 23(9):1059-67. Hsue PY, Hunt PW, Schnell A, Kalapus SC, Hoh R, Ganz P, Martin JN, Deeks SG. PMID: 19390417.
      View in: PubMed   Mentions: 168     Fields:    Translation:HumansCells
    226. Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients. PLoS One. 2009; 4(4):e5277. Jacobson MA, Ditmer DP, Sinclair E, Martin JN, Deeks SG, Hunt P, Mocarski ES, Shiboski C. PMID: 19381272.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    227. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009 Apr 30; 360(18):1815-26. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD, NA-ACCORD Investigators . PMID: 19339714.
      View in: PubMed   Mentions: 462     Fields:    Translation:HumansCells
    228. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis. 2009 Mar 15; 48(6):787-94. Kelley CF, Kitchen CM, Hunt PW, Rodriguez B, Hecht FM, Kitahata M, Crane HM, Willig J, Mugavero M, Saag M, Martin JN, Deeks SG. PMID: 19193107.
      View in: PubMed   Mentions: 147     Fields:    Translation:Humans
    229. Use of saliva as a lubricant in anal sexual practices among homosexual men. . 2009 Feb 01; 50(2):162-7. Butler LM, Osmond DH, Jones AG, Martin JN. PMID: 19131893.
      View in: PubMed   Mentions:
    230. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood. 2009 Apr 23; 113(17):3978-89. Ferre AL, Hunt PW, Critchfield JW, Young DH, Morris MM, Garcia JC, Pollard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL. PMID: 19109229.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansCells
    231. Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS One. 2008; 3(12):e3843. Yiannoutsos CT, An MW, Frangakis CE, Musick BS, Braitstein P, Wools-Kaloustian K, Ochieng D, Martin JN, Bacon MC, Ochieng V, Kimaiyo S. PMID: 19048109.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    232. Awareness of Kaposi's sarcoma-associated herpesvirus among men who have sex with men. Sex Transm Dis. 2008 Dec; 35(12):1011-4. Phillips AM, Jones AG, Osmond DH, Pollack LM, Catania JA, Martin JN. PMID: 18665016.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    233. In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine. J Virol. 2009 Feb; 83(4):2038-43. Paredes R, Sagar M, Marconi VC, Hoh R, Martin JN, Parkin NT, Petropoulos CJ, Deeks SG, Kuritzkes DR. PMID: 19019971.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    234. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J Virol. 2009 Jan; 83(1):329-35. Hatano H, Delwart EL, Norris PJ, Lee TH, Dunn-Williams J, Hunt PW, Hoh R, Stramer SL, Linnen JM, McCune JM, Martin JN, Busch MP, Deeks SG. PMID: 18945778.
      View in: PubMed   Mentions: 112     Fields:    Translation:HumansCells
    235. Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA. 2008 Aug 06; 300(5):506-7. Geng EH, Emenyonu N, Bwana MB, Glidden DV, Martin JN. PMID: 18677022.
      View in: PubMed   Mentions: 117     Fields:    Translation:Humans
    236. HIV-induced changes in T cell signaling pathways. J Immunol. 2008 May 15; 180(10):6490-500. Schweneker M, Favre D, Martin JN, Deeks SG, McCune JM. PMID: 18453567.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    237. Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension. AIDS. 2008 Apr 23; 22(7):825-33. Hsue PY, Deeks SG, Farah HH, Palav S, Ahmed SY, Schnell A, Ellman AB, Huang L, Dollard SC, Martin JN. PMID: 18427200.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    238. Oral candidiasis as a marker of HIV disease progression among Zimbabwean women. . 2008 Apr 15; 47(5):579-84. Chidzonga MM, Mwale M, Malvin K, Martin JN, Greenspan JS, Shiboski CH. PMID: 18176326.
      View in: PubMed   Mentions:
    239. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control. J Virol. 2008 Jun; 82(11):5398-407. Emu B, Sinclair E, Hatano H, Ferre A, Shacklett B, Martin JN, McCune JM, Deeks SG. PMID: 18353945.
      View in: PubMed   Mentions: 127     Fields:    Translation:HumansCells
    240. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. 2008 Jan 01; 197(1):126-33. Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, Page-Shafer K, Hsue P, Emu B, Krone M, Lampiris H, Douek D, Martin JN, Deeks SG. PMID: 18171295.
      View in: PubMed   Mentions: 331     Fields:    Translation:HumansCells
    241. History-adjusted marginal structural models for estimating time-varying effect modification. Am J Epidemiol. 2007 Nov 01; 166(9):985-93. Petersen ML, Deeks SG, Martin JN, van der Laan MJ. PMID: 17875580.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    242. Moving toward clarity on 2 fronts in the epidemiology of Kaposi sarcoma-associated herpesvirus infection. J Infect Dis. 2007 Jul 15; 196(2):173-5. Martin JN. PMID: 17570101.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    243. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet. 2007 Jun; 39(6):733-40. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, Colombo S, Brown EE, Shupert WL, Phair J, Goedert JJ, Buchbinder S, Kirk GD, Telenti A, Connors M, O'Brien SJ, Walker BD, Parham P, Deeks SG, McVicar DW, Carrington M. PMID: 17496894.
      View in: PubMed   Mentions: 368     Fields:    Translation:HumansCells
    244. Clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitors. J Virol. 2007 Apr; 81(7):3240-50. Ray N, Harrison JE, Blackburn LA, Martin JN, Deeks SG, Doms RW. PMID: 17251281.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    245. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med. 2007 Apr 01; 175(7):737-42. Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, Havlir DV. PMID: 17218620.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCTClinical Trials
    246. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol. 2007 Apr; 36(2):294-301. Gange SJ, Kitahata MM, Saag MS, Bangsberg DR, Bosch RJ, Brooks JT, Calzavara L, Deeks SG, Eron JJ, Gebo KA, Gill MJ, Haas DW, Hogg RS, Horberg MA, Jacobson LP, Justice AC, Kirk GD, Klein MB, Martin JN, McKaig RG, Rodriguez B, Rourke SB, Sterling TR, Freeman AM, Moore RD. PMID: 17213214.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    247. Partial treatment interruptions. Curr Opin HIV AIDS. 2007 Jan; 2(1):46-55. Deeks SG, Martin JN. PMID: 19372865.
      View in: PubMed   Mentions:    Fields:    
    248. Interruption of enfuvirtide in HIV-1 infected adults with incomplete viral suppression on an enfuvirtide-based regimen. J Infect Dis. 2007 Feb 01; 195(3):387-91. Deeks SG, Lu J, Hoh R, Neilands TB, Beatty G, Huang W, Liegler T, Hunt P, Martin JN, Kuritzkes DR. PMID: 17205477.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    249. Continued evolution in gp41 after interruption of enfuvirtide in subjects with advanced HIV type 1 disease. AIDS Res Hum Retroviruses. 2006 Dec; 22(12):1260-6. Kitchen CM, Lu J, Suchard MA, Hoh R, Martin JN, Kuritzkes DR, Deeks SG. PMID: 17209769.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    250. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS. 2006 Nov 28; 20(18):2275-83. Hsue PY, Hunt PW, Sinclair E, Bredt B, Franklin A, Killian M, Hoh R, Martin JN, McCune JM, Waters DD, Deeks SG. PMID: 17117013.
      View in: PubMed   Mentions: 127     Fields:    Translation:HumansCells
    251. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006 Dec; 12(12):1365-71. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC. PMID: 17115046.
      View in: PubMed   Mentions: 1584     Fields:    Translation:HumansAnimalsCells
    252. Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen. Clin Infect Dis. 2006 Nov 15; 43(10):1329-36. Hatano H, Hunt P, Weidler J, Coakley E, Hoh R, Liegler T, Martin JN, Deeks SG. PMID: 17051502.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    253. Rapid emergence of enfuvirtide resistance in HIV-1-infected patients: results of a clonal analysis. . 2006 Sep; 43(1):60-4. Lu J, Deeks SG, Hoh R, Beatty G, Kuritzkes BA, Martin JN, Kuritzkes DR. PMID: 16885776.
      View in: PubMed   Mentions:
    254. Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia. J Infect Dis. 2006 Oct 01; 194(7):926-30. Hunt PW, Harrigan PR, Huang W, Bates M, Williamson DW, McCune JM, Price RW, Spudich SS, Lampiris H, Hoh R, Leigler T, Martin JN, Deeks SG. PMID: 16960780.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCellsCTClinical Trials
    255. IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells. AIDS Res Ther. 2006 Jul 21; 3:18. Nomura LE, Emu B, Hoh R, Haaland P, Deeks SG, Martin JN, McCune JM, Nixon DF, Maecker HT. PMID: 16859558.
      View in: PubMed   Mentions: 8     Fields:    
    256. Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses. J Virol. 2006 Jun; 80(12):6155-64. Deeks SG, Schweighardt B, Wrin T, Galovich J, Hoh R, Sinclair E, Hunt P, McCune JM, Martin JN, Petropoulos CJ, Hecht FM. PMID: 16731954.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCells
    257. The independent effect of drug resistance on T cell activation in HIV infection. AIDS. 2006 Mar 21; 20(5):691-9. Hunt PW, Deeks SG, Bangsberg DR, Moss A, Sinclair E, Liegler T, Bates M, Tsao G, Lampiris H, Hoh R, Martin JN. PMID: 16514299.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    258. Variations in plasmacytoid dendritic cell (PDC) and myeloid dendritic cell (MDC) levels in HIV-infected subjects on and off antiretroviral therapy. J Clin Immunol. 2006 Jan; 26(1):55-64. Schmidt B, Fujimura SH, Martin JN, Levy JA. PMID: 16418803.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    259. High-risk sexual behavior in adults with genotypically proven antiretroviral-resistant HIV infection. . 2005 Dec 01; 40(4):463-71. Chin-Hong PV, Deeks SG, Liegler T, Hagos E, Krone MR, Grant RM, Martin JN. PMID: 16280703.
      View in: PubMed   Mentions:
    260. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J Virol. 2005 Nov; 79(22):14169-78. Emu B, Sinclair E, Favre D, Moretto WJ, Hsue P, Hoh R, Martin JN, Nixon DF, McCune JM, Deeks SG. PMID: 16254352.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansCells
    261. Seroconversion following nonoccupational postexposure prophylaxis against HIV. Clin Infect Dis. 2005 Nov 15; 41(10):1507-13. Roland ME, Neilands TB, Krone MR, Katz MH, Franses K, Grant RM, Busch MP, Hecht FM, Shacklett BL, Kahn JO, Bamberger JD, Coates TJ, Chesney MA, Martin JN. PMID: 16231265.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    262. The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection. Clin Infect Dis. 2005 Nov 01; 41(9):1335-40. Lo JC, Kazemi MR, Hsue PY, Martin JN, Deeks SG, Schambelan M, Mulligan K. PMID: 16206112.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    263. Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection. J Infect Dis. 2005 Nov 01; 192(9):1537-44. Deeks SG, Hoh R, Neilands TB, Liegler T, Aweeka F, Petropoulos CJ, Grant RM, Martin JN. PMID: 16206068.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCellsCTClinical Trials
    264. Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States. AIDS. 2004 Oct 21; 18(15):2065-73. Pinkerton SD, Martin JN, Roland ME, Katz MH, Coates TJ, Kahn JO. PMID: 15577628.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    265. Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimen. AIDS. 2004 Sep 24; 18(14):1965-6. Friend J, Parkin N, Liegler T, Martin JN, Deeks SG. PMID: 15353986.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    266. HIV RNA testing in the context of nonoccupational postexposure prophylaxis. J Infect Dis. 2004 Aug 01; 190(3):598-604. Roland ME, Elbeik TA, Kahn JO, Bamberger JD, Coates TJ, Krone MR, Katz MH, Busch MP, Martin JN. PMID: 15243937.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    267. Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia. AIDS. 2004 Apr 30; 18(7):981-9. Karlsson AC, Younger SR, Martin JN, Grossman Z, Sinclair E, Hunt PW, Hagos E, Nixon DF, Deeks SG. PMID: 15096800.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    268. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood. 2004 Aug 15; 104(4):942-7. Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB, Hunt P, Martin JN, Kahn JO, Levy J, McGrath MS, Hecht FM. PMID: 15117761.
      View in: PubMed   Mentions: 359     Fields:    Translation:HumansCells
    269. Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior. AIDS. 2004 Mar 26; 18(5):787-92. Martin JN, Roland ME, Neilands TB, Krone MR, Bamberger JD, Kohn RP, Chesney MA, Franses K, Kahn JO, Coates TJ, Katz MH. PMID: 15075514.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCTClinical Trials
    270. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation. 2004 Apr 06; 109(13):1603-8. Hsue PY, Lo JC, Franklin A, Bolger AF, Martin JN, Deeks SG, Waters DD. PMID: 15023877.
      View in: PubMed   Mentions: 200     Fields:    Translation:Humans
    271. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus. Arch Intern Med. 2004 Jan 12; 164(1):46-54. Pinkerton SD, Martin JN, Roland ME, Katz MH, Coates TJ, Kahn JO. PMID: 14718321.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    272. Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1. J Infect Dis. 2004 Jan 15; 189(2):312-21. Deeks SG, Martin JN, Sinclair E, Harris J, Neilands TB, Maecker HT, Hagos E, Wrin T, Petropoulos CJ, Bredt B, McCune JM. PMID: 14722897.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    273. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS. 2004 Jan 02; 18(1):81-8. Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, Osmond DH. PMID: 15090833.
      View in: PubMed   Mentions: 100     Fields:    Translation:Humans
    274. Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells. J Immunol Methods. 2003 Dec; 283(1-2):141-53. Karlsson AC, Martin JN, Younger SR, Bredt BM, Epling L, Ronquillo R, Varma A, Deeks SG, McCune JM, Nixon DF, Sinclair E. PMID: 14659906.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    275. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS. 2003 Sep 05; 17(13):1907-15. Hunt PW, Deeks SG, Rodriguez B, Valdez H, Shade SB, Abrams DI, Kitahata MM, Krone M, Neilands TB, Brand RJ, Lederman MM, Martin JN. PMID: 12960823.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansCells
    276. Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene. J Virol. 2003 Jun; 77(12):6743-52. Karlsson AC, Deeks SG, Barbour JD, Heiken BD, Younger SR, Hoh R, Lane M, Sällberg M, Ortiz GM, Demarest JF, Liegler T, Grant RM, Martin JN, Nixon DF. PMID: 12767994.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    277. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis. 2003 May 15; 187(10):1534-43. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, Lampiris H, Deeks SG. PMID: 12721933.
      View in: PubMed   Mentions: 382     Fields:    Translation:HumansCells
    278. Diagnosis and epidemiology of human herpesvirus 8 infection. Semin Hematol. 2003 Apr; 40(2):133-42. Martin JN. PMID: 12704590.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    279. Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function. . 2002 Dec 15; 31(5):472-7. Jacobson MA, Khayam-Bashi H, Martin JN, Black D, Ng V. PMID: 12473834.
      View in: PubMed   Mentions:
    280. Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults. J Virol. 2002 Nov; 76(21):11104-12. Barbour JD, Wrin T, Grant RM, Martin JN, Segal MR, Petropoulos CJ, Deeks SG. PMID: 12368352.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    281. Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia. AIDS. 2002 Jan 25; 16(2):201-7. Deeks SG, Barbour JD, Grant RM, Martin JN. PMID: 11807304.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    282. Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic. JAMA. 2002 Jan 09; 287(2):221-5. Osmond DH, Buchbinder S, Cheng A, Graves A, Vittinghoff E, Cossen CK, Forghani B, Martin JN. PMID: 11779265.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsPHPublic Health
    283. Use of epidemiologically well-defined subjects and existing immunofluorescence assays to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies. J Clin Microbiol. 2000 Feb; 38(2):696-701. Martin JN, Amad Z, Cossen C, Lam PK, Kedes DH, Page-Shafer KA, Osmond DH, Forghani B. PMID: 10655369.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    284. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era. J Infect Dis. 1999 Dec; 180(6):1809-18. Martin JN, Rose DA, Hadley WK, Perdreau-Remington F, Lam PK, Gerberding JL. PMID: 10558935.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    285. Kaposi's sarcoma-associated herpesvirus and sexual transmission of cancer risk. Curr Opin Oncol. 1999 Nov; 11(6):508-15. Martin JN, Osmond DH. PMID: 10550016.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    286. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. J Infect Dis. 1999 Sep; 180(3):896-9. Martin JN, Perdreau-Remington F, Kartalija M, Pasi OG, Webb M, Gerberding JL, Chambers HF, Täuber MG, Lee BL. PMID: 10438389.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    Jeffrey's Networks
    Concepts (768)
    Derived automatically from this person's publications.
    _
    Co-Authors (150)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _